US20210137107A1 - Surface disinfectant with residual biocidal property - Google Patents
Surface disinfectant with residual biocidal property Download PDFInfo
- Publication number
- US20210137107A1 US20210137107A1 US17/154,934 US202117154934A US2021137107A1 US 20210137107 A1 US20210137107 A1 US 20210137107A1 US 202117154934 A US202117154934 A US 202117154934A US 2021137107 A1 US2021137107 A1 US 2021137107A1
- Authority
- US
- United States
- Prior art keywords
- formulation
- weight
- range
- disinfectant
- oxazoline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000645 desinfectant Substances 0.000 title claims abstract description 45
- 230000003115 biocidal effect Effects 0.000 title claims abstract description 32
- 239000000203 mixture Substances 0.000 claims abstract description 146
- 238000009472 formulation Methods 0.000 claims abstract description 105
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 35
- -1 poly(2-ethyl-2-oxazoline) Polymers 0.000 claims abstract description 29
- 150000003856 quaternary ammonium compounds Chemical class 0.000 claims abstract description 26
- 239000004094 surface-active agent Substances 0.000 claims abstract description 22
- 229920006187 aquazol Polymers 0.000 claims abstract description 21
- 239000012861 aquazol Substances 0.000 claims abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 42
- 229920005596 polymer binder Polymers 0.000 claims description 26
- 239000002491 polymer binding agent Substances 0.000 claims description 26
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 claims description 22
- 150000001875 compounds Chemical class 0.000 claims description 22
- 229920001519 homopolymer Polymers 0.000 claims description 17
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 13
- 229920000642 polymer Polymers 0.000 claims description 12
- 230000000694 effects Effects 0.000 claims description 8
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 7
- 238000011012 sanitization Methods 0.000 claims description 7
- 125000003504 2-oxazolinyl group Chemical group O1C(=NCC1)* 0.000 claims description 6
- 239000003002 pH adjusting agent Substances 0.000 claims description 3
- 239000003205 fragrance Substances 0.000 abstract description 25
- 239000000758 substrate Substances 0.000 abstract description 25
- 239000002657 fibrous material Substances 0.000 abstract description 2
- 239000012669 liquid formulation Substances 0.000 description 35
- 238000000034 method Methods 0.000 description 21
- 238000004140 cleaning Methods 0.000 description 20
- 238000012360 testing method Methods 0.000 description 20
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 18
- 230000009467 reduction Effects 0.000 description 17
- 239000007788 liquid Substances 0.000 description 15
- 150000003868 ammonium compounds Chemical class 0.000 description 14
- 239000002689 soil Substances 0.000 description 13
- 150000001298 alcohols Chemical class 0.000 description 12
- 150000001412 amines Chemical class 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 11
- 125000000217 alkyl group Chemical group 0.000 description 11
- 229920001577 copolymer Polymers 0.000 description 11
- 239000000565 sealant Substances 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 239000000047 product Substances 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- 239000000080 wetting agent Substances 0.000 description 10
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 9
- 0 [1*]N(CC[2*])C([3*])=O Chemical compound [1*]N(CC[2*])C([3*])=O 0.000 description 9
- 239000001257 hydrogen Substances 0.000 description 9
- 229910052739 hydrogen Inorganic materials 0.000 description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 9
- 206010011409 Cross infection Diseases 0.000 description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- 125000003545 alkoxy group Chemical group 0.000 description 8
- 125000003118 aryl group Chemical group 0.000 description 8
- 238000006116 polymerization reaction Methods 0.000 description 8
- 125000003342 alkenyl group Chemical group 0.000 description 7
- 239000004599 antimicrobial Substances 0.000 description 7
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 7
- 125000002091 cationic group Chemical group 0.000 description 7
- 239000012141 concentrate Substances 0.000 description 7
- 208000015181 infectious disease Diseases 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 6
- 230000000845 anti-microbial effect Effects 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 239000011521 glass Substances 0.000 description 6
- 239000002736 nonionic surfactant Substances 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- 239000003380 propellant Substances 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 239000000443 aerosol Substances 0.000 description 5
- 239000003139 biocide Substances 0.000 description 5
- 239000000969 carrier Substances 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 230000000813 microbial effect Effects 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 229920000765 poly(2-oxazolines) Polymers 0.000 description 5
- 235000002639 sodium chloride Nutrition 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- 235000007586 terpenes Nutrition 0.000 description 5
- PUAQLLVFLMYYJJ-UHFFFAOYSA-N 2-aminopropiophenone Chemical compound CC(N)C(=O)C1=CC=CC=C1 PUAQLLVFLMYYJJ-UHFFFAOYSA-N 0.000 description 4
- QKMBGRILGQHRCA-UHFFFAOYSA-N 4,5-dihydro-1,3-oxazol-3-ium 4-methylbenzenesulfonate Chemical group C1C[NH+]=CO1.CC1=CC=C(S([O-])(=O)=O)C=C1 QKMBGRILGQHRCA-UHFFFAOYSA-N 0.000 description 4
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 4
- 239000004743 Polypropylene Substances 0.000 description 4
- 101710194948 Protein phosphatase PhpP Proteins 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 229920006190 aquazol 500 Polymers 0.000 description 4
- 239000012865 aquazol 500 Substances 0.000 description 4
- 239000003093 cationic surfactant Substances 0.000 description 4
- 239000000919 ceramic Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 229910052736 halogen Inorganic materials 0.000 description 4
- 150000002367 halogens Chemical class 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 4
- HWGNBUXHKFFFIH-UHFFFAOYSA-I pentasodium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O HWGNBUXHKFFFIH-UHFFFAOYSA-I 0.000 description 4
- 125000005010 perfluoroalkyl group Chemical group 0.000 description 4
- 229920001155 polypropylene Polymers 0.000 description 4
- 125000001453 quaternary ammonium group Chemical group 0.000 description 4
- 150000003839 salts Chemical group 0.000 description 4
- 235000019832 sodium triphosphate Nutrition 0.000 description 4
- IIACRCGMVDHOTQ-UHFFFAOYSA-N sulfamic acid Chemical compound NS(O)(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-N 0.000 description 4
- RYCLIXPGLDDLTM-UHFFFAOYSA-J tetrapotassium;phosphonato phosphate Chemical compound [K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])([O-])=O RYCLIXPGLDDLTM-UHFFFAOYSA-J 0.000 description 4
- 241001515965 unidentified phage Species 0.000 description 4
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 3
- NYEZZYQZRQDLEH-UHFFFAOYSA-N 2-ethyl-4,5-dihydro-1,3-oxazole Chemical compound CCC1=NCCO1 NYEZZYQZRQDLEH-UHFFFAOYSA-N 0.000 description 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 3
- KJQGKUWBIDLKEQ-UHFFFAOYSA-N 4,5-dihydro-1,3-oxazol-2-ylsilane Chemical group [SiH3]C1=NCCO1 KJQGKUWBIDLKEQ-UHFFFAOYSA-N 0.000 description 3
- IZZGFZMCAZTIKO-UHFFFAOYSA-N 4,5-dihydro-1,3-oxazol-3-ium methanesulfonate Chemical group CS(=O)(=O)O.O1C=NCC1 IZZGFZMCAZTIKO-UHFFFAOYSA-N 0.000 description 3
- MUHATGLZCJFIEM-UHFFFAOYSA-N 4,5-dihydro-1,3-oxazol-3-ium;trifluoromethanesulfonate Chemical group C1C[NH+]=CO1.[O-]S(=O)(=O)C(F)(F)F MUHATGLZCJFIEM-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 3
- 241000588914 Enterobacter Species 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 206010029803 Nosocomial infection Diseases 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 241000589516 Pseudomonas Species 0.000 description 3
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- 125000003282 alkyl amino group Chemical group 0.000 description 3
- 125000000304 alkynyl group Chemical group 0.000 description 3
- 150000001450 anions Chemical class 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 239000012620 biological material Substances 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 125000005019 carboxyalkenyl group Chemical group 0.000 description 3
- 125000004181 carboxyalkyl group Chemical group 0.000 description 3
- 150000007942 carboxylates Chemical class 0.000 description 3
- 230000009351 contact transmission Effects 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 125000004093 cyano group Chemical group *C#N 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 231100000517 death Toxicity 0.000 description 3
- SCJSLULDABCBLN-UHFFFAOYSA-L disodium;carbonate;pentahydrate Chemical compound O.O.O.O.O.[Na+].[Na+].[O-]C([O-])=O SCJSLULDABCBLN-UHFFFAOYSA-L 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 230000002538 fungal effect Effects 0.000 description 3
- 125000003147 glycosyl group Chemical group 0.000 description 3
- 125000001475 halogen functional group Chemical group 0.000 description 3
- 239000008233 hard water Substances 0.000 description 3
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 3
- 229920000371 poly(diallyldimethylammonium chloride) polymer Polymers 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 238000005096 rolling process Methods 0.000 description 3
- 229910000077 silane Inorganic materials 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 3
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 3
- 125000000101 thioether group Chemical group 0.000 description 3
- 150000003573 thiols Chemical group 0.000 description 3
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 2
- KEZYHIPQRGTUDU-UHFFFAOYSA-N 2-[dithiocarboxy(methyl)amino]acetic acid Chemical compound SC(=S)N(C)CC(O)=O KEZYHIPQRGTUDU-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- LHXDLQBQYFFVNW-UHFFFAOYSA-N Fenchone Chemical compound C1CC2(C)C(=O)C(C)(C)C1C2 LHXDLQBQYFFVNW-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 241000588915 Klebsiella aerogenes Species 0.000 description 2
- 241000588747 Klebsiella pneumoniae Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- 229920002873 Polyethylenimine Polymers 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 2
- JYYOBHFYCIDXHH-UHFFFAOYSA-N carbonic acid;hydrate Chemical compound O.OC(O)=O JYYOBHFYCIDXHH-UHFFFAOYSA-N 0.000 description 2
- 229920006317 cationic polymer Polymers 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000012864 cross contamination Methods 0.000 description 2
- 230000000249 desinfective effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 229940092559 enterobacter aerogenes Drugs 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 239000003999 initiator Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 239000005445 natural material Substances 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920006254 polymer film Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 238000009991 scouring Methods 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- HQAITFAUVZBHNB-UHFFFAOYSA-N sodium;pentahydrate Chemical compound O.O.O.O.O.[Na] HQAITFAUVZBHNB-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- LHXDLQBQYFFVNW-XCBNKYQSSA-N (+)-Fenchone Natural products C1C[C@]2(C)C(=O)C(C)(C)[C@H]1C2 LHXDLQBQYFFVNW-XCBNKYQSSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-M 1,1-dioxo-1,2-benzothiazol-3-olate Chemical compound C1=CC=C2C([O-])=NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-M 0.000 description 1
- CZLMRJZAHXYRIX-UHFFFAOYSA-N 1,3-dioxepane Chemical compound C1CCOCOC1 CZLMRJZAHXYRIX-UHFFFAOYSA-N 0.000 description 1
- LAVARTIQQDZFNT-UHFFFAOYSA-N 1-(1-methoxypropan-2-yloxy)propan-2-yl acetate Chemical compound COCC(C)OCC(C)OC(C)=O LAVARTIQQDZFNT-UHFFFAOYSA-N 0.000 description 1
- RWNUSVWFHDHRCJ-UHFFFAOYSA-N 1-butoxypropan-2-ol Chemical compound CCCCOCC(C)O RWNUSVWFHDHRCJ-UHFFFAOYSA-N 0.000 description 1
- BPIUIOXAFBGMNB-UHFFFAOYSA-N 1-hexoxyhexane Chemical compound CCCCCCOCCCCCC BPIUIOXAFBGMNB-UHFFFAOYSA-N 0.000 description 1
- FENFUOGYJVOCRY-UHFFFAOYSA-N 1-propoxypropan-2-ol Chemical compound CCCOCC(C)O FENFUOGYJVOCRY-UHFFFAOYSA-N 0.000 description 1
- WMDZKDKPYCNCDZ-UHFFFAOYSA-N 2-(2-butoxypropoxy)propan-1-ol Chemical compound CCCCOC(C)COC(C)CO WMDZKDKPYCNCDZ-UHFFFAOYSA-N 0.000 description 1
- GZMAAYIALGURDQ-UHFFFAOYSA-N 2-(2-hexoxyethoxy)ethanol Chemical compound CCCCCCOCCOCCO GZMAAYIALGURDQ-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- CUDYYMUUJHLCGZ-UHFFFAOYSA-N 2-(2-methoxypropoxy)propan-1-ol Chemical compound COC(C)COC(C)CO CUDYYMUUJHLCGZ-UHFFFAOYSA-N 0.000 description 1
- JECYNCQXXKQDJN-UHFFFAOYSA-N 2-(2-methylhexan-2-yloxymethyl)oxirane Chemical compound CCCCC(C)(C)OCC1CO1 JECYNCQXXKQDJN-UHFFFAOYSA-N 0.000 description 1
- XYVAYAJYLWYJJN-UHFFFAOYSA-N 2-(2-propoxypropoxy)propan-1-ol Chemical compound CCCOC(C)COC(C)CO XYVAYAJYLWYJJN-UHFFFAOYSA-N 0.000 description 1
- ROKSAUSPJGWCSM-UHFFFAOYSA-N 2-(7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl)ethanol Chemical compound C1C2C(C)(C)C1CC=C2CCO ROKSAUSPJGWCSM-UHFFFAOYSA-N 0.000 description 1
- COBPKKZHLDDMTB-UHFFFAOYSA-N 2-[2-(2-butoxyethoxy)ethoxy]ethanol Chemical compound CCCCOCCOCCOCCO COBPKKZHLDDMTB-UHFFFAOYSA-N 0.000 description 1
- WFSMVVDJSNMRAR-UHFFFAOYSA-N 2-[2-(2-ethoxyethoxy)ethoxy]ethanol Chemical compound CCOCCOCCOCCO WFSMVVDJSNMRAR-UHFFFAOYSA-N 0.000 description 1
- WAEVWDZKMBQDEJ-UHFFFAOYSA-N 2-[2-(2-methoxypropoxy)propoxy]propan-1-ol Chemical compound COC(C)COC(C)COC(C)CO WAEVWDZKMBQDEJ-UHFFFAOYSA-N 0.000 description 1
- PLFJWWUZKJKIPZ-UHFFFAOYSA-N 2-[2-[2-(2,6,8-trimethylnonan-4-yloxy)ethoxy]ethoxy]ethanol Chemical compound CC(C)CC(C)CC(CC(C)C)OCCOCCOCCO PLFJWWUZKJKIPZ-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- UPGSWASWQBLSKZ-UHFFFAOYSA-N 2-hexoxyethanol Chemical compound CCCCCCOCCO UPGSWASWQBLSKZ-UHFFFAOYSA-N 0.000 description 1
- CTHJQRHPNQEPAB-UHFFFAOYSA-N 2-methoxyethenylbenzene Chemical compound COC=CC1=CC=CC=C1 CTHJQRHPNQEPAB-UHFFFAOYSA-N 0.000 description 1
- YEYKMVJDLWJFOA-UHFFFAOYSA-N 2-propoxyethanol Chemical compound CCCOCCO YEYKMVJDLWJFOA-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 241000588626 Acinetobacter baumannii Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical group NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 201000003883 Cystic fibrosis Diseases 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- RUPBZQFQVRMKDG-UHFFFAOYSA-M Didecyldimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC RUPBZQFQVRMKDG-UHFFFAOYSA-M 0.000 description 1
- FARBQUXLIQOIDY-UHFFFAOYSA-M Dioctyldimethylammonium chloride Chemical compound [Cl-].CCCCCCCC[N+](C)(C)CCCCCCCC FARBQUXLIQOIDY-UHFFFAOYSA-M 0.000 description 1
- 206010049119 Emotional distress Diseases 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- KDFGDPLUSXZGGS-UHFFFAOYSA-N N.N.N.N.N Chemical compound N.N.N.N.N KDFGDPLUSXZGGS-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920002413 Polyhexanide Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 229920002334 Spandex Polymers 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical class OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000012963 UV stabilizer Substances 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- NJSSICCENMLTKO-HRCBOCMUSA-N [(1r,2s,4r,5r)-3-hydroxy-4-(4-methylphenyl)sulfonyloxy-6,8-dioxabicyclo[3.2.1]octan-2-yl] 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)O[C@H]1C(O)[C@@H](OS(=O)(=O)C=2C=CC(C)=CC=2)[C@@H]2OC[C@H]1O2 NJSSICCENMLTKO-HRCBOCMUSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- VEZXCJBBBCKRPI-UHFFFAOYSA-N beta-propiolactone Chemical compound O=C1CCO1 VEZXCJBBBCKRPI-UHFFFAOYSA-N 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 229920003118 cationic copolymer Polymers 0.000 description 1
- 238000010538 cationic polymerization reaction Methods 0.000 description 1
- 238000012656 cationic ring opening polymerization Methods 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- UHZZMRAGKVHANO-UHFFFAOYSA-M chlormequat chloride Chemical compound [Cl-].C[N+](C)(C)CCCl UHZZMRAGKVHANO-UHFFFAOYSA-M 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 229930007927 cymene Natural products 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical class CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- SCXCDVTWABNWLW-UHFFFAOYSA-M decyl-dimethyl-octylazanium;chloride Chemical compound [Cl-].CCCCCCCCCC[N+](C)(C)CCCCCCCC SCXCDVTWABNWLW-UHFFFAOYSA-M 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940028356 diethylene glycol monobutyl ether Drugs 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- GVUBZTSOFTYNQE-UHFFFAOYSA-M dimethyl-octadecyl-(3-trihydroxysilylpropyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCC[Si](O)(O)O GVUBZTSOFTYNQE-UHFFFAOYSA-M 0.000 description 1
- WSFMFXQNYPNYGG-UHFFFAOYSA-M dimethyl-octadecyl-(3-trimethoxysilylpropyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCC[Si](OC)(OC)OC WSFMFXQNYPNYGG-UHFFFAOYSA-M 0.000 description 1
- XXBDWLFCJWSEKW-UHFFFAOYSA-N dimethylbenzylamine Chemical compound CN(C)CC1=CC=CC=C1 XXBDWLFCJWSEKW-UHFFFAOYSA-N 0.000 description 1
- MQRJBSHKWOFOGF-UHFFFAOYSA-L disodium;carbonate;hydrate Chemical compound O.[Na+].[Na+].[O-]C([O-])=O MQRJBSHKWOFOGF-UHFFFAOYSA-L 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- PGQAXGHQYGXVDC-UHFFFAOYSA-N dodecyl(dimethyl)azanium;chloride Chemical compound Cl.CCCCCCCCCCCCN(C)C PGQAXGHQYGXVDC-UHFFFAOYSA-N 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229940032049 enterococcus faecalis Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000013265 extended release Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229930006735 fenchone Natural products 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 208000027096 gram-negative bacterial infections Diseases 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229930002839 ionone Natural products 0.000 description 1
- 150000002499 ionone derivatives Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Chemical class 0.000 description 1
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 1
- VUQUOGPMUUJORT-UHFFFAOYSA-N methyl 4-methylbenzenesulfonate Chemical compound COS(=O)(=O)C1=CC=C(C)C=C1 VUQUOGPMUUJORT-UHFFFAOYSA-N 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 230000003641 microbiacidal effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- JCGNDDUYTRNOFT-UHFFFAOYSA-N oxolane-2,4-dione Chemical compound O=C1COC(=O)C1 JCGNDDUYTRNOFT-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 150000004686 pentahydrates Chemical class 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000010665 pine oil Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- LLHKCFNBLRBOGN-UHFFFAOYSA-N propylene glycol methyl ether acetate Chemical compound COCC(C)OC(C)=O LLHKCFNBLRBOGN-UHFFFAOYSA-N 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000005956 quaternization reaction Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 239000006254 rheological additive Substances 0.000 description 1
- 208000026425 severe pneumonia Diseases 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 239000004759 spandex Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- XSROQCDVUIHRSI-UHFFFAOYSA-N thietane Chemical compound C1CSC1 XSROQCDVUIHRSI-UHFFFAOYSA-N 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- JLGLQAWTXXGVEM-UHFFFAOYSA-N triethylene glycol monomethyl ether Chemical compound COCCOCCOCCO JLGLQAWTXXGVEM-UHFFFAOYSA-N 0.000 description 1
- YUYCVXFAYWRXLS-UHFFFAOYSA-N trimethoxysilane Chemical compound CO[SiH](OC)OC YUYCVXFAYWRXLS-UHFFFAOYSA-N 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 229940043810 zinc pyrithione Drugs 0.000 description 1
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical class [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
- A01N33/02—Amines; Quaternary ammonium compounds
- A01N33/12—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/08—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
- A01N25/10—Macromolecular compounds
Definitions
- the present invention relates to the field of disinfectant formulations, and more specifically, to a disinfectant formulation imparting a residual biocidal property.
- a hospital-acquired infection is an infection whose development is favored by a hospital or healthcare environment.
- Such maladies typically are fungal or bacterial infections and can afflict the victim locally or systemically.
- Nosocomial infections can cause severe pneumonia as well as infections of the urinary tract, bloodstream, and other parts of the body.
- a trio of pathogens is commonly found in healthcare settings and together account for approximately one-third of nosocomial infections: coagulase-negative Staphylococci (15%), Candida species (11%), and Escherichia coli (10%).
- ESKAPE pathogens Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species—possess antibiotic resistance and are implicated in nearly half of all nosocomial infections. Their resistance to one or more biocidal agents makes such infections particularly dangerous.
- the broad nutritional versatility of Pseudomonas permits its survival in extreme environments, including survival on surfaces not intensively cleaned and sterilized.
- This pathogen's ubiquity in the hospital environment makes it a leading cause of Gram-negative nosocomial infections.
- Particularly vulnerable are immune-compromised patients (e.g. those afflicted with cystic fibrosis, cancer, or burns).
- Direct contact transmission involves a patient contacting either a contaminated patient or worker.
- care providers move through the healthcare institution, they come into contact with its many patients.
- These workers unwittingly act in a manner analogous to bees in a garden, “pollinating” rooms and wards as they care for residents.
- Indirect contact transmission occurs when the patient contacts a contaminated object or surface.
- the healthcare environment presents an array of articles capable of passively vectoring pathogens.
- Nosocomial infections further deal a serious blow to the volume, quality, and cost of healthcare provided by hospitals and other institutions.
- HAI-related deaths occurring annually in the United States, an estimated two million more victims are forced to endure the physical ravages and emotional distress associated with these serious and avoidable illnesses.
- Household environments also face microbes.
- a main disadvantage associated with consumer disinfectants and sanitizers is that, while they can be effective at initially killing microbes, the surface is easily and quickly re-contaminated through contact, airborne microbes, and un-killed residual microbes before treatment. While some of the disinfectants would continue to offer some control if simply left on the surface, this would result in a greasy or tacky residue that would be easily negated by casual contact with the surface.
- a home care and household cleaner that kills microbes quickly on contact, then acts as a residual disinfectant but yet does not have this undesirable sticky or tacky effect.
- Such cleaners may be useful for general purpose household cleaning, bathroom cleaning, and spray protectants.
- VOC volatile organic content
- a biofilm is generally defined as a layer of microorganisms adhering to the surface of a structure, which may be organic or inorganic, that secrete a protective coating that is biological in origin.
- Biofilms present a large problem for public health because of increased resistance of biofilm-associated organisms to antimicrobial agents and for the potential of biofilm borne organisms to cause infections.
- Current disinfectants do not have the ability to kill biofilms or to seal or lock-in biofilms on surfaces to prevent cross-contamination events and to prevent out growth.
- There are limited solutions for surface biofilm problems For example, there is a building body of evidence that surface biofilms pose a problem in the healthcare setting for the above mentioned reasons.
- biofilms are a recognized problem of possible contamination within the food industry. Other industries face similar concerns.
- a solution targeted at potential biofilm problem areas that can be used to eradicate biofilms.
- the residual biocidal property prefferably associated with the treated surface, such that it may continue to provide microbial reduction for an extended period of time after application.
- the present invention relates to a disinfectant formulation imparting a residual biocidal property.
- the disinfectant formulation comprises a polymer binder, wherein the polymer binder is an oxazoline homopolymer or an extended or a modified polymer based on an oxazoline homopolymer, and a biocidal compound.
- the disinfectant formulation further comprises a carrier.
- the oxazoline homopolymer has a structure of:
- R 1 is a hydrogen, alkyl, alkenyl, alkoxy, alkylamino, alkynyl, allyl, amino, anilino, aryl, benzyl, carboxyl, carboxyalkyl, carboxyalkenyl, cyano, glycosyl, halo, hydroxyl, oxazolinium mesylate, oxazolinium tosylate, oxazolinium triflate, silyl oxazolinium, phenolic, polyalkoxy, quaternary ammonium, thiol, or thioether group;
- R 2 is a hydrogen, alkyl, alkenyl, alkoxy, alkylamino, alkynyl, allyl, amino, anilino, aryl, benzyl, carboxyl, carboxyalkyl, carboxyalkenyl, cyano, glycosyl, halo, hydroxyl, oxazolinium mesy
- an article having the disinfectant formulation(s) of the present invention is provided as well as methods of making, using and applying the disinfectant formulation(s).
- microbe or “microbial” should be interpreted to refer to any of the microscopic organisms studied by microbiologists or found in the use environment of a treated article. Such organisms include, but are not limited to, bacteria and fungi as well as other single-celled organisms such as mold, mildew and algae. Viral particles and other infectious agents are also included in the term microbe.
- Antimicrobial further should be understood to encompass both microbicidal and microbistatic properties. That is, the term comprehends microbe killing, leading to a reduction in number of microbes, as well as a retarding effect of microbial growth, wherein numbers may remain more or less constant (but nonetheless allowing for slight increase/decrease).
- antimicrobial to denote a broad spectrum activity (e.g. against bacteria and fungi).
- efficacy against a particular microorganism or taxonomic rank the more focused term will be used (e.g. antifungal to denote efficacy against fungal growth in particular).
- the present invention is directed to a disinfectant formulation.
- the disinfectant formulation is in a liquid form.
- the composition of the disinfectant formulation comprises a biocidal compound and a polymer binder.
- the composition may further comprise a solvent (such as water or a low molecular weight alcohol), a surfactant, a colorant, a fragrance, among other components.
- a liquid composition is formulated having surface disinfection and residual biocidal properties.
- the formulation can be applied to a surface by spraying, rolling, fogging, wiping or other means.
- the formulation acts as a surface disinfectant, killing infectious microbes present on the surface.
- the liquid formulation leaves a residual protective film on the surface.
- the residual film possesses a biocidal property, enabling it to maintain protection of the surface against microbial contamination for an extended time period after its application.
- the surface disinfectant formulation imparts a film with the capacity to quickly kill bacteria and other germs for at least 24 hours after deposit of the film on the treated surface.
- quick kill generally refers to a time period of about 30 seconds to about 5 minutes. The film will remain on the surface and is durable to multiple touches and wearing of the surface.
- the disinfectant formulation is a liquid composition comprising a polymer binder, a biocidal compound, a carrier such as a solvent, and other optional components such as fragrances.
- the disinfectant formulation is a biofilm sealant.
- the biofilm sealant once applied to a surface forms a polymer film.
- the polymer film is applied wet and dries as a film layer to lock in and prevent subsequent outgrowth of biofilm microorganisms.
- the biofilm sealant although preferably in the form of a liquid, may also take other forms such as a gel, or other form. Once the biofilm sealant is in place, the microbes of the biofilm have limited access to oxygen and exogenous nutrients.
- the biofilm sealant has the potential to seal in bacteria but also to provide extended release of antimicrobials into the film to kill the microorganisms in the biofilm.
- the biofilm sealant comprises a polymer binder and a biocidal compound.
- the biocidal compound may include, but is not limited to, any biocidal compound set forth herein.
- the biofilm sealant comprises an oxazoline homopolymer as the polymer binder.
- the oxazoline homopolymer may have any of the structures as set forth herein.
- the biofilm sealant comprises a polymer binder, a biocidal compound, and an enzyme(s).
- the enzyme is to assist in degrading the biofilm and provide for enhanced antimicrobial penetration by the biocidal agent and ultimately biofilm removal.
- Example enzymes include, but are not limited to, proteinase, DNase, RNase, and carbohydrate specific enzymes that can degrade the extracellular matrix associated with the biofilm.
- the biofilm selant comprises a polymer binder and an antibody as a biological material for slow release into the film.
- the antibody functionality will bind to the biofilm microbe to prevent cross-contamination.
- the biofilm sealant comprises a polymer binder, and a bacteriophage or a mixture of bacteriophages as a biological material for slow release into the film.
- the bacteriophage act as a targeted antimicrobial agent to kill biofilm associated organisms.
- the biofilm sealant comprises a polymer binder, and a mixture of bacteriophages, antimicrobial agents, enzymes and antibodies as a biological material for slow release into the film.
- the polymer binder is an oxazoline homopolymer.
- the oxazoline homopolymer has the following structure:
- R 1 and R 2 are end groups determined by the polymerization techniques used to synthesize oxazoline homopolymer.
- R 1 and R 2 are independently selected and include, but are not limited to, hydrogen, alkyl, alkenyl, alkoxy, alkylamino, alkynyl, allyl, amino, anilino, aryl, benzyl, carboxyl, carboxyalkyl, carboxyalkenyl, cyano, glycosyl, halo, hydroxyl, oxazolinium mesylate, oxazolinium tosylate, oxazolinium triflate, silyl oxazolinium, phenolic, polyalkoxy, quaternary ammonium, thiol, or thioether groups.
- R 2 could include a macrocyclic structure formed during synthesis as a consequence of intramolecular attack.
- R 1 is a methyl group and R 2 is oxazolinium tosylate if methyl tosylate is used as the initiator in the cationic initiated polymerization of oxazoline.
- R 3 is an end group determined by the type of oxazoline used in the preparation of the polymer binder of this invention.
- R 3 includes, but is not limited to, hydrogen, alkyl, alkenyl, alkoxy, aryl, benzyl, hydroxyalkyl, or perfluoroalkyl.
- R 3 is an ethyl group if ethyloxazoline is the monomer used to prepare the polymer binder for the present invention.
- n is the degree of oxazoline polymerization in the homopolymer. n is in a range of 1 to 1,000,000. Preferably, n is in a range of 500 to 250,000; most preferably, n is in a range of 2500 to 100,000.
- extended or modified polymers with some variations based on the oxazoline homopolymer are also suitable for the present invention.
- the techniques and options for performing chemical or molecular structure variations or modifications to oxazoline should be familiar to those skilled in the art.
- a class of extended or modified polymers based on oxazoline homopolymer can be represented with the following molecular structure:
- R 1 and R 3 have the same definition as those given in the above oxazoline homopolymer.
- B is additional monomer repeating unit linked to oxazoline in a coploymer.
- the types of arrangement of the repeating units between B and oxazoline in the copolymer can include, but are not limited to, block, alternating, periodic, or combinations thereof. There is no limitation as to the types of B that can be used to copolymerize with or modify the oxazoline of the present invention.
- n is the degree of polymerization for an oxazoline repeating unit; n in the copolymer is in a range of 1 to 1,000,000 and the degree of polymerization for B repeating unit in the copolymer m is in a range of 0 to 500,000 at the same time.
- n is in a range of 500 to 250,000 and m is in a range of 20 to 10,000; and most preferably, n is in a range of 2500 to 100,000 and m is in a range of 50 to 5,000.
- B could also be linked to oxazoline as an end group in a cationic polymerization by using B as a cationic initiator if B itself is already a quaternary ammonium compound.
- B can be, for example, ethyleneimine with the following molecular structure:
- R 1 and R 2 end groups have the same definition as those outlined for oxazoline homopolymer.
- R 3 includes, but is not limited to, hydrogen, alkyl, alkenyl, alkoxy, aryl, benzyl, hydroxyalkyl, or perfluoroalkyl.
- R 4 includes, but is not limited to, hydrogen, alkyl, alkenyl, alkoxy, aryl, benzyl, hydroxyalkyl, or perfluoroalkyl.
- m is in a range of 0 to 500,000; preferably, in a range of 20 to 10,000; and most preferably, in a range of 50 to 5,000.
- n is in a range of 1 to 1,000,000; preferably, 500 to 250,000; most preferably, in a range of 2500 to 100,000.
- oxazoline and ethyleneimine copolymer can be phased into two steps, for example.
- a first step a cationic ring opening polymerization technique can be used to make polyoxazoline homopolymer.
- the polyoxazoline made in the first step can be hydrolyzed to convert part of polyoxazoline repeating units into polyethyleneimine.
- oxazoline-ethylenimine copolymer can be made with the appropriate respective monomers, an oxazoline and an aziridine. The result would be a cationic polymer having the above structure.
- the degree of polymerization for oxazoline repeating unit n in the copolymer is in a range of 1 to 1,000,000 and the degree of polymerization for ethyleneimine repeating unit in the copolymer m is in a range of 0 to 500,000 at the same time.
- n is in a range of 500 to 250,000 and m is in a range of 20 to 10,000, and most preferably n is in a range of 2500 to 100,000 and m is in a range of 50 to 5,000.
- the nitrogen in the ethyleneimine repeating unit could be further quaternized to generate the following cationic copolymer:
- R 1 , R 2 , R 3 and R 4 have the same meaning as those designated in the above oxazoline-ethyleneimine copolymer.
- R 5 includes, but is not limited to, a hydrogen, methyl, ethyl, propyl, or other types of alkyl group.
- the corresponding anion X ⁇ is a halogen, sulfonate, sulfate, phosphonate, phosphate, carbonate/bicarbonate, hydroxy, or carboxylate.
- n and m are also the same as those described in oxazoline-ethyleneimine copolymer.
- Polydiallyldimethylammonium chloride Another example of B that can be used for the present invention is polydiallyldimethylammonium chloride.
- Polyethyloxazoline modified with polydiallyldimethylammonium chloride has the following structure:
- R 1 and R 4 have the same meaning as described in previous example for quaternized oxazoline-ethyleneimine copolymer.
- R 2 and R 3 independently, include, but are not limited to, short chain alkyl groups such as C 1 to C 6 .
- the corresponding anion X ⁇ is a halogen, sulfonate, sulfate, phosphonate, phosphate, carbonate/bicarbonate, hydroxy, or carboxylate.
- n and m are defined and numbered the same as in previous examples.
- B could be other olefins including, but not limited to, diallyldimethylammonium chloride, styrene, methoxystyrene, and methoxyethene.
- Ethyloxazoline can also be copolymerized with heterocyclic monomers such as oxirane, thietane, 1,3-dioxepane, oxetan-2-one, and tetrahydrofuran to enhance the performance of the polymer for the present invention.
- the binder used in this invention could also employ pendant oxazoline groups on a polymer backbone, such as an acrylic or styrene based polymer, or a copolymer containing acrylic or styrene.
- polyethyloxazolines examples include, but are not limited to, Aquazol 500 from Polymer Chemistry Innovations, Inc.
- the amount of polymer binder that can be used in the liquid formulation can vary somewhat depending upon desired length of residual activity of the composition and the nature of all the other components in the composition.
- the amount of polymer binder in the liquid formulation is in a range of 0.1% to 20% based on the weight of liquid formulation.
- the amount of polymer binder in the liquid formulation is more preferably in a range of 0.5% to 10%, and most preferably in a range of 0.8% to 5%.
- the amount of polymer binder in the liquid formulation is more preferably in a range of 0.1% to 10%, and most preferably in a range of 0.1% to 5%.
- the polymer binder preferably is water-soluble and can be readily removed from surface if any buildup is noticed. Present in small amounts, it nonetheless can provide a durable bond between biocidal compound and the treated surface to facilitate residual efficacy.
- the biocidal compound may be a quaternary ammonium compound (QAC) with the following molecular structure:
- R 1 , R 2 , R 3 , and R 4 are independently selected and include, but are not limited to, alkyl, alkoxy, or aryl, either with or without heteroatoms, or saturated or non-saturated. Some or all of the functional groups may be the same.
- the corresponding anion X ⁇ includes, but is not limited to, a halogen, sulfonate, sulfate, phosphonate, phosphate, carbonate/bicarbonate, hydroxy, or carboxylate.
- QACs include, but are not limited to, n-alkyl dimethyl benzyl ammonium chloride, di-n-octyl dimethyl ammonium chloride, dodecyl dimethyl ammonium chloride, n-alkyl dimethyl benzyl ammonium saccharinate, and 3-(trimethoxysilyl) propyldimethyloctadecyl ammonium chloride.
- QACs Combinations of monomeric QACs are preferred to be used for the invention.
- a specific example of QAC combination is N-alkyl dimethyl benzyl ammonium chloride (40%); N-octyl decyl dimethyl ammonium chloride (30%); di-n-decyl dimethyl ammonium chloride (15%); and di-n-dioctyl dimethyl ammonium chloride (15%).
- the percentage is the weight percentage of individual QAC based on the total weight of blended QACs composition.
- R 1 , R 2 , R 5 , and R 6 independently, include, but are not limited to, hydrogen, methyl, ethyl, propyl or other longer carbon alkyl groups.
- R 3 and R 4 are independently selected and include, but are not limited to, methylene, ethylene, propylene or other longer alkylene linking groups.
- n is the degree of polymerization; n is an integer in a range of from 2 to 10,000.
- cationic polymers with the above structure include but are not limited to, polyamines derived from dimethylamine and epichlorohydrin such as Superfloc C-572 commercially available from Kemira Chemicals.
- Still another polymeric QAC suitable for the invention is poly diallyldimethylammonium chloride or polyDADMAC.
- QACs useful for the present invention are those chemical compounds with biguanide moiety in the molecule.
- examples of this class of cationic antimicrobials include, but are not limited to, PHMB and chlorhexidine.
- Examples of commercially available quaternary ammonium compounds include, but are not limited to, Bardac 205M and 208M from Lonza, and BTC885 from Stepan Company.
- the biocidal compound may be a weak acid, which has been shown to be particularly effective in bathroom cleaners.
- citric, sulfamic also known as amidosulfonic acid, amidosulfuric acid, aminosulfonic acid, and sulfamidic acid
- glycolic, lactic, lauric and capric acids are useful as both an effective biocide and a cleaning agent for soap scum and hard wart deposits.
- silane quaternary salts such as 3(trihydroxysilyl)propyldimethyloctadecyl ammonium chloride. These may have the added benefit of reacting to the surface being treated for an enhancement of the residual properties.
- biocidal compounds suitable for use in the present liquid formulation span a broad range of antimicrobials, biocides, sanitizers, and disinfectants.
- a water soluble or dispersible biocidal compound is preferred, although biocides soluble in alcohol may be alternatively employed.
- biocidal compounds suitable for use in the present formulation include triclosan, zinc pyrithione, metal salts and oxides, phenols, botanicals, halogens, peroxides, heterocyclic antimicrobials, aldehydes, and alcohols.
- the concentration of biocidal compound in the formulation can be in a range of 0.05% to 20% based on the weight of the liquid composition.
- a liquid formulation for a healthcare application preferably in a range of 0.1% to 20%, and more preferably in a range of 0.5% to 3%.
- a liquid formulation for all-purpose and bathroom cleaners preferably in a range of 0.05% to 10%.
- a formulation for a protectant preferably in a range of 0.05% to 2%.
- the carrier or media for the liquid formulation of this invention can be any solvent that is volatile and allow easy evaporation at ambient condition.
- liquid carriers include, but are not limited to, water and low molecular weight alcohols such as C1 to C8 alkanols. Specific examples include, but are not limited to, ethanol, isopropyl alcohol, butanol, pentanol, and combinations thereof.
- alkylene glycol ether examples include, but are not limited to, ethylene glycol monopropyl ether, ethylene glycol monobutyl ether, ethylene glycol monohexyl ether, ethylene clycol monohexyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monobutyl ether, diethylene glycol monohexyl ether, triethylene glycol monomethyl ether, triethylene glycol monoethyl ether, triethylene glycol monobutyl ether, propylene glycol methyl ether, propylene glycol methyl ether acetate, propylene glycol n-butyl ether, dipropylene glycol n-butyl ether, dipropylene glycol methyl ether, dipropylene glycol methyl ether acetate, propylene glycol n-propyl ether, dipropylene glycol n-propyl ether, dipropylene glycol methyl
- solvents for use in the invention is based on terpenes and their derivatives such as terpene alcohols, terpene esters, terpene ethers, or terpene aldehydes.
- terpene alcohols such as pine oil, lemon oil, limonene, pinene, cymene, myrcene, fenchone, borneol, nopol, cineole, ionone and the like.
- a preferred carrier in a liquid formulation for a home care cleaning application is water.
- a propellant may be needed in the composition.
- a variety of propellants or mixtures can be used for the present invention and should be familiar to those skilled in the art.
- C1 to C10 hydrocarbons or halogenated hydrocarbons are typical propellants in aerosol compositions known to the industry.
- propellants include, but are not limited to, pentane, butane, propane, and methane.
- Other types of propellants that can be used for the present invention also include compressed air, nitrogen, or carbon dioxide.
- a bag on valve package may be used to aerosol the product without directly add a propellant to the composition.
- Either a single solvent or a mixture of the above solvents can be used for the present invention.
- the types of solvents used for the present invention may depend upon the intended uses of the residual disinfectant composition. For example, if the composition of the present invent is intended for home care use, cleaning the contaminated surfaces free of all types of dirt or soil may be of primary interest. Liquid carrier or media that assist and enhance the removal of soil may be formulation of the invention.
- the residual disinfectant formulation or composition of the present invention may desire to include alkyl or multi-alkyl glycol ethers for better cleaning performance in the home care version of the formulation of the present invention.
- the primary goal of the residual disinfectant composition is to be used at a health care facility where the major concern is hospital acquired infection
- quick drying of the liquid composition of the present invention may be more desirable than cleaning dirt or soil out of the surfaces.
- Low molecular weight alcohols should be considered to help the liquid formulation of the present invent dry fast after the application. Also, a low molecular weight alcohol in the liquid formulation will strengthen the sanitizing activity of the liquid composition.
- a mixture of water and low molecular weight alcohol is preferred.
- the amount of alcohol present in the liquid formulation is preferred to be at such a level that the liquid formulation is capable of forming a zerotropic mixture between the alcohol and water.
- a minimum amount of alcohol, if present, in the liquid composition is 10%.
- the alcohol concentration is 30%, and most preferably the alcohol concentration is at least 50% based on the weight of liquid formulation for the health care use of the composition of the invention.
- a surfactant or wetting agent may be employed.
- the surfactant assists the liquid formulation to spread and evenly coat the surface being treated.
- the surfactant additionally contributes to the formation of a zeotropic mixture between alcohol and water, thus facilitating a rapid and uniform drying of the liquid formulation once being applied onto surface.
- a surfactant also plays an important role in the residual disinfectant liquid formulation of the present invention for home care use if the soil cleaning performance is the key feature the product is designed to possess.
- Surfactants appropriate for the present liquid formulation include, but are not limited to, those that are nonionic, anionic, or amphoteric in nature.
- Examples of commercially available wetting agents include, but are not limited to, Ecosurf SA-4 or Tergitol TMN-3 from Dow Chemical, and Q2-5211 from Dow Corning.
- An amine oxide surfactant is preferred especially when the QAC is used as the biocidal compound in the formulation.
- ethoxylated alcohols with different amounts of ethylene oxides or HLB values can be used.
- ethoxylated alcohols include, but are not limited to, Triton X-100 (Dow Chemical, Midland, Mich.), Ecosurf EH nonionic surfactant series from Dow Chemical, Tergitol nonionic surfactant series from Dow Chemical, the Surfonic surfactant series from Huntsman Corp., the Neodol surfactant series from Shell, the Ethox surfactant series from Ethox Chemicals and the Tomadol surfactant series from Air Products and Chemicals, Inc.
- nonionic surfactants include alkylpolyglucosides. Examples include the Glucopon Series from BASF and the Ecoteric series from Huntsman.
- silane-based surfactants examples include but, are not limited to, silicone polyethers organofunctional or reactive silane wetting agents, and fluorochemical based wetting agents.
- the content of the surfactant in the liquid formulation is in a range of 0% to 10%, preferably in a range of 0.01% to 5%.
- a liquid formulation of the present invention for home care use may need appropriate pH condition.
- a high pH product may be desired in order to effectively remove grease soils commonly found in the area.
- soap scum and hard water deposits may be the primary concern.
- a low pH product may be more appropriate for such a purpose.
- Example of pH adjusting agents that can be used include, but are not limited to, triethanolamine, diethanolamine, monoethanolamine, sodium hydroxide, sodium carbonate, potassium hydroxide, potassium carbonate, calcium carbonate, citric acid, acetic acid, hydrochloric acid, sulfamic acid, sulfuric acid and the like.
- Additional functional components may be included in the liquid composition of the present invention. Additional components include, but are not limited to, chelants, compatibilizers, coupling agents, corrosion inhibitors, rheology modifiers, fragrances, colorants, preservatives, UV stabilizers, optical brighteners, and active ingredient indicators.
- the liquid solution comprises a polymer binder, a quaternary ammonium compound, a silicone-based surfactant, and ethanol.
- the liquid formulation can be made or mixed by any conventional method known to one of ordinary skill in the art. There are no preferred addition procedures for the formulation of the present invention provided that the formulation is ultimately homogeneous, compatible and stable. For example, if the polymer binder is a solid, it may be preferable to first dissolve or disperse the polymer in a carrier such as water or alcohol to make a stock polymer binder liquid dispersion. The stock polymer binder liquid dispersion may be readily added into the formulation of the present invention during the mixing procedure.
- the liquid formulation may be applied by a variety of means. If sprayed, the liquid formulation advantageously may be supplied in a conventional bottle with a sprayer.
- the sprayer can be a trigger sprayer.
- an aerosol can also be used to deliver the liquid formulation on to surfaces. Additional application means include, but are not limited to, fogging, rolling, brushing, mopping, and using a wipe by a variety of application devices. It is within the scope of the present invention that wipe products can also be made comprising or pre-treated with the disinfectant formulation(s) of the present invention, for example, for off-the-shelf sale or use.
- a wipe having up to 24-hour residual sanitization activity.
- the wipe is capable of protecting a hard surface from microbial growth and protection against bacteria without leaving a significant residue or build-up.
- the wipe is comprised of a substrate and a formulation applied on the substrate or present in the substrate of the wipe.
- the wipe formulation provides a solid transparent film water soluble enough to be easily removed with additional cleanings yet durable enough to remain on the surface even after being touched.
- the substrate is any fibrous material capable of absorbing and/or adsorbing water, preferably at least three times its weight in water.
- the substrate comprises a synthetic material, a natural material, or a combination thereof.
- synthetic materials include, but are not limited to, polypropylene, polystyrene, polyester, nylon, rayon, acrylic, spandex, and a combination thereof.
- natural materials include, but are not limited to, cotton, linen, silk, wool, hemp, flax, and a combination thereof.
- the substrate may be woven or non-woven.
- a non-woven substrate may be made by any number of manufacturing methods.
- the resulting non-woven substrate may be, but is not limited to, melt-blown, coformed, spunbonded, airlaid, hydroentangled, spunlaced, bonded, carded, laminated, or a combination thereof.
- a substrate may comprise a melt-blown polymeric material.
- the wipe formulation comprises a biocidal compound, a polymer binder and a wetting agent/surfactant.
- the wipe formulation may comprise a cationic containing compound that is designed to compete with the quaternary ammonium compound(s) for anionic species sites on the substrate. Salts with high ionic strengths can also be used. Examples of salts for use in the wipe formulation include, but are not limited to, potassium citrate, sodium citrate, magnesium sulphate, sodium chloride, ammonium chloride, potassium chloride, and a combination thereof
- the wipe formulation provides initial disinfection then once dried leaves a residual protective film on the surface.
- the film possesses biocidal properties with the ability to kill bacteria, for example, within a 5-minute contact time for up to 24 hours after initial application.
- the wipe formulation comprises a poly(2-ethyl-2-oxazoline), a quaternary ammonium compound or combination of quaternary ammonium compounds, an alcohol ethoxylate, water, and an optional fragrance.
- Quaternary ammonium compounds are especially suited for this wipe application as they provide protection against a broad range of microorganisms. Examples of such compounds are commercially available from Stepan Chemical under the trade name BTC885. BTC885 contains 50% of a blend of quaternary ammonium compounds. A similar material is also commercially available from Lonza under the trade name Bardac 205M.
- the quaternary ammonium compound and the binder are in a ratio of quaternary ammonium compound to binder of 1:4 to 1:1.
- the wipe formulation comprises a poly(2-ethyl-2-oxazoline) in an amount of 1 weight % to 5 weight %, wherein the weight percentage is based on the total weight of the wipe formulation.
- the wipe formulation comprises a quaternary ammonium compound in an amount of at least 0.2 weight percent, preferably 0.2 weight percent to 2 weight percent, wherein the weight percentage is based on the total weight of the wipe formulation.
- the wipe formulation comprises a nonionic surfactant.
- the nonionic surfactant is an alcohol ethoxylate.
- the wipe formulation comprises the alcohol ethoxylate in an amount of 0.05 weight % to 0.5 weight %, wherein the weight percentage is based on the total weight of the wipe formulation.
- a preferred alcohol ethoxylate is a linear alcohol ethoxylate with at least 9 moles of ethylene oxide, more preferably with at least 12 moles of ethylene oxide.
- an alcohol ethoxylate such as in this group, when used in the formulation of the present invention surprisingly and favorably contributes to the aesthetics of the resulting film by drying to a hard transparent film (as opposed to a tacky, hazy film) yet remains water soluble enough to allow release of the quaternary ammonium compound(s) for antimicrobial efficacy.
- a weak acid including, but not limited to, citric acid, lactic acid, sulfamic, acid, glycolic acid, or a combination thereof can be added to the formulation to increase efficacy against gram negative bacteria and aid in hard water stain or soap scum soil removal.
- Ethylenediaminetetraacetic acid, disodium salt or EDTA disodium salt can be added to the formulation to increase antimicrobial efficacy in the presence of hard water.
- the wipe formulation optionally comprises a fragrance. If a fragrance is present, the wipe formulation preferably comprises a fragrance in an amount of 0 weight % to 0.5 weight %, wherein the weight percentage is based on the total weight of the wipe formulation.
- Water is a suitable carrier for inert and active materials. Solvents such as ethanol or isopropanol are optionally added to decrease drying time.
- the wipe formulation of the present invention is effective for the above purposes without requiring other components to be present in the formulation, although other components may be present.
- the wipe formulation of the present invention is effective for its residual sanitization activity without hydrogen peroxide as a component of the formulation.
- the wet formulation subsequently may be wiped dry with a dry cloth or paper towel.
- the invention also relates to an article treated with a disinfectant formulation in accordance with aspects of the invention.
- Formulations were tested for residual efficacy using the EPA 01-1A protocol. Briefly, bacteria were added to a glass slide and allowed to dry on the surface. The formulation was then sprayed onto the surface and dried to form a transparent film. Once a film had formed, the glass slide was exposed to alternating wet and dry cycles using the Gardner wear tester as described in the protocol. In between each cycle the slide was re-inoculated with bacteria. After the appropriate number of wear and re-inoculations (48 passes and 11 re-inoculations for healthcare formulation and 24 passes 5 re-inoculation for homecare formulation) the slide was exposed to bacteria for the indicated time frame (i.e. 5 minutes) followed by recovery in an appropriate neutralizing solution.
- the indicated time frame i.e. 5 minutes
- initial efficacy of the composition of the present invention was also tested according to ASTM E 1153.
- a modified ASTM D4488 was used to evaluate the hard surface cleaning performance for the home care composition of the present invention.
- a soil of the following composition was used for the evaluation.
- a Gardner wear tester was used in the cleaning test. Scouring pads of around 1 cm width were attached to the abrasion boat for the wearing. Around 4 grams of test formulation was placed in a weighing boat. The attached scouring pad was dipped into the weighing boat to pick up the testing formulation.
- the cleaning process started immediately after the pad is wetted with the cleaning formulation. Seven wearing cycles (back and forth) were used in the test.
- the following formulation in the example uses alcohol as the major carrier in order to provide fast drying property to the liquid formulations.
- compositions are formulated using water as the carrier. They are intended for homecare use where VOC regulations prohibit most use of high levels of organic solvents such as alcohols.
- Enterobacter aerogenes was the bacterial for H1 testing and Staphylococcus aureus was the bacteria used in the testing for the rest of the formulations.
- the testing results demonstrate that the H1 to H5 all provide residual efficacy to the treated surfaces.
- the cleaning performance was also evaluated using the modified ASTM D4488 test method.
- a concentrate of a water based formulation is prepared by removing a portion of the water from the formulation, concentrating the remaining raw materials. The resulting concentrate can then be diluted back to use strength prior to use.
- the 5 times and 10 times concentrates are typically used in the janitorial and sanitization supply industries with customers in the hospitality area. Concentrates can be prepared at 15 times, 20 times, or even higher levels, as desired, and still be within the scope of the present invention. Concentrates are desirable in these industries as it reduces shipping costs and conserves storage space.
- Table 10 illustrates example concentrate formulations in an embodiment of the invention.
- Formula 1 Formula 2
- Formula 3 Formula 4
- Formula 5 Active Quaternary Quaternary Quaternary Quaternary Quaternary Quaternary Quaternary Ingredient
- Ammonium Ammonium Ammonium Ammonium Ammonium Ammonium Blend blend blend blend blend Polymer 3 Glycidoxypropyl- Trimethoxysilyl- acrylic polyamide polyoxazoline trimethoxysilane propyl emulsion resin (Polyethyleneimine)
- SSP-060 Aesthetics hazy film tacky film when dry clear, non- clear, non- clear, non- tacky film tacky film tacky film tacky film tacky film tacky film Associated NT* NT* 0.5 log 1.8 log 5 log Log Reduction reduction reduction reduction *indicates not tested (NT) due to poor aesthetics
- Wipe formulations A-I were prepared and tested on various substrates.
Abstract
Description
- This application is a divisional application which claims priority from U.S. continuation-in-part application Ser. No. 15/625,612 filed on Jun. 16, 2017, which is a continuation-in-part application claiming priority from U.S. continuation-in-part patent application Ser. No. 15/162,068, filed on May 23, 2016, which claims priority from U.S. patent application Ser. No. 14/948962, filed on No. 23, 2015, which claims priority from U.S. provisional patent application Ser. No. 62/084,917, filed on Nov. 26, 2014, and from U.S. provisional patent application Ser. No. 62/127,075, filed on Mar. 2, 2015, and from U.S. provisional patent application Ser. No. 62/166,403, filed on May 26, 2015, in the United States Patent and Trademark Office. The disclosures of which are incorporated herein by reference in their entireties.
- The present invention relates to the field of disinfectant formulations, and more specifically, to a disinfectant formulation imparting a residual biocidal property.
- Microbes exist everywhere in the modern world. While some are beneficial to humans and the environment, others may have significant negative consequences for contaminated articles as well as the persons, animals and ecological members coming in contact with them. There are a number of industries and environments where such microbes are especially prevalent.
- A hospital-acquired infection (HAI; alternatively a “nosocomial infection”) is an infection whose development is favored by a hospital or healthcare environment. Such maladies typically are fungal or bacterial infections and can afflict the victim locally or systemically. Nosocomial infections can cause severe pneumonia as well as infections of the urinary tract, bloodstream, and other parts of the body.
- Nosocomial infections have severe medical implications for patients and care providers. In the United States, data suggest that approximately 1.7 million instances of hospital-associated infections occur each year, with nearly 100,000 deaths resulting therefrom. European data and surveys indicate Gram-negative bacterial infections alone account for 8,000-10,000 deaths each year.
- Several aggravating factors contribute to the high HAI rate. Hospitals, urgent care centers, nursing homes, and similar facilities focus their treatments on those with serious illnesses and injuries. As a result, these facilities house abnormally highly concentrated populations of patients with weakened immune systems.
- A trio of pathogens is commonly found in healthcare settings and together account for approximately one-third of nosocomial infections: coagulase-negative Staphylococci (15%), Candida species (11%), and Escherichia coli (10%).
- Worse, it is the more robust disease-causing pathogens that are present in such environments. The six so-called “ESKAPE pathogens”—Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species—possess antibiotic resistance and are implicated in nearly half of all nosocomial infections. Their resistance to one or more biocidal agents makes such infections particularly dangerous.
- In particular, the broad nutritional versatility of Pseudomonas permits its survival in extreme environments, including survival on surfaces not intensively cleaned and sterilized. This pathogen's ubiquity in the hospital environment makes it a leading cause of Gram-negative nosocomial infections. Particularly vulnerable are immune-compromised patients (e.g. those afflicted with cystic fibrosis, cancer, or burns).
- The most common means of HAIs is through direct or indirect contact transmission. Direct contact transmission involves a patient contacting either a contaminated patient or worker. As care providers move through the healthcare institution, they come into contact with its many patients. These workers unwittingly act in a manner analogous to bees in a garden, “pollinating” rooms and wards as they care for residents.
- Indirect contact transmission occurs when the patient contacts a contaminated object or surface. The healthcare environment presents an array of articles capable of passively vectoring pathogens.
- Nosocomial infections further deal a serious blow to the volume, quality, and cost of healthcare provided by hospitals and other institutions. In addition to the roughly 100,000 HAI-related deaths occurring annually in the United States, an estimated two million more victims are forced to endure the physical ravages and emotional distress associated with these serious and avoidable illnesses.
- Institutions have reacted by creating policies to impose more stringent cleanliness and disinfection requirements upon staff and the patient environment. These programs typically include frequent hand-washing and frequent disinfection of surfaces. Despite implementation of programs to curb nosocomial infections, infections still occur at unacceptably high rates.
- Household environments also face microbes. A main disadvantage associated with consumer disinfectants and sanitizers is that, while they can be effective at initially killing microbes, the surface is easily and quickly re-contaminated through contact, airborne microbes, and un-killed residual microbes before treatment. While some of the disinfectants would continue to offer some control if simply left on the surface, this would result in a greasy or tacky residue that would be easily negated by casual contact with the surface. Thus, there is a desire for a home care and household cleaner that kills microbes quickly on contact, then acts as a residual disinfectant but yet does not have this undesirable sticky or tacky effect. Such cleaners may be useful for general purpose household cleaning, bathroom cleaning, and spray protectants.
- A difference between hospital and healthcare cleaners and household products is the allowable VOC (volatile organic content). The regulations for most non-aerosol household consumer disinfectants are a maximum of 1% VOC.
- The food service industry also faces outbreaks in contamination of pathogens in the workplace and spreading disease out to consumers. Even though food manufacturers adopt vigorous hygiene plans and comply with tight government hygiene regulations, major outbreaks of microbes are still reported occasionally that causes serious illness among consumers. Disinfectants with residual activities should effectively alleviate the issue.
- A biofilm is generally defined as a layer of microorganisms adhering to the surface of a structure, which may be organic or inorganic, that secrete a protective coating that is biological in origin. Biofilms present a large problem for public health because of increased resistance of biofilm-associated organisms to antimicrobial agents and for the potential of biofilm borne organisms to cause infections. Thus, there is a need for a solution to disinfection with regard to biofilms. Current disinfectants do not have the ability to kill biofilms or to seal or lock-in biofilms on surfaces to prevent cross-contamination events and to prevent out growth. There are limited solutions for surface biofilm problems. For example, there is a building body of evidence that surface biofilms pose a problem in the healthcare setting for the above mentioned reasons. In addition, biofilms are a recognized problem of possible contamination within the food industry. Other industries face similar concerns. Thus, there is a need for a solution targeted at potential biofilm problem areas that can be used to eradicate biofilms.
- In summary, there remains a need for a formulation able to confer a residual biocidal activity to treated surfaces. It would be further advantageous if the formulation were combined with a surface disinfectant, to enable a single cleaning to both disinfect and impart the residual biocidal effect.
- It further would be advantageous for the residual biocidal property to be durably associated with the treated surface, such that it may continue to provide microbial reduction for an extended period of time after application.
- It further would be advantageous if there is a formulation(s) effective across a wide range of industries and applications.
- The present invention relates to a disinfectant formulation imparting a residual biocidal property. The disinfectant formulation comprises a polymer binder, wherein the polymer binder is an oxazoline homopolymer or an extended or a modified polymer based on an oxazoline homopolymer, and a biocidal compound. The disinfectant formulation further comprises a carrier.
- In an aspect of the invention the oxazoline homopolymer has a structure of:
- wherein R1 is a hydrogen, alkyl, alkenyl, alkoxy, alkylamino, alkynyl, allyl, amino, anilino, aryl, benzyl, carboxyl, carboxyalkyl, carboxyalkenyl, cyano, glycosyl, halo, hydroxyl, oxazolinium mesylate, oxazolinium tosylate, oxazolinium triflate, silyl oxazolinium, phenolic, polyalkoxy, quaternary ammonium, thiol, or thioether group; R2 is a hydrogen, alkyl, alkenyl, alkoxy, alkylamino, alkynyl, allyl, amino, anilino, aryl, benzyl, carboxyl, carboxyalkyl, carboxyalkenyl, cyano, glycosyl, halo, hydroxyl, oxazolinium mesylate, oxazolinium tosylate, oxazolinium triflate, silyl oxazolinium, phenolic, polyalkoxy, quaternary ammonium, thiol, or thioether group or a macrocyclic structure; R3 is a hydrogen, alkyl, alkenyl, alkoxy, aryl, benzyl, hydroxyalkyl, or perfluoroalkyl group; and n is in a range of 1 to 1,000,000.
- In another aspect of the invention other features of the disinfectant formulation(s) are provided.
- In yet another aspect of the invention, an article having the disinfectant formulation(s) of the present invention is provided as well as methods of making, using and applying the disinfectant formulation(s).
- Further areas of applicability of the present invention will become apparent from the detailed description provided hereinafter. It should be understood that the detailed description and specific examples, while indicating the preferred embodiments of the invention, are intended for purposes of illustration only and are not intended to limit the scope of the invention
- The following description of the embodiments of the present invention is merely exemplary in nature and is in no way intended to limit the invention, its application, or uses. The present invention has broad potential application and utility, which is contemplated to be adaptable across a wide range of industries. The following description is provided herein solely by way of example for purposes of providing an enabling disclosure of the invention, but does not limit the scope or substance of the invention.
- As used herein, the terms “microbe” or “microbial” should be interpreted to refer to any of the microscopic organisms studied by microbiologists or found in the use environment of a treated article. Such organisms include, but are not limited to, bacteria and fungi as well as other single-celled organisms such as mold, mildew and algae. Viral particles and other infectious agents are also included in the term microbe.
- “Antimicrobial” further should be understood to encompass both microbicidal and microbistatic properties. That is, the term comprehends microbe killing, leading to a reduction in number of microbes, as well as a retarding effect of microbial growth, wherein numbers may remain more or less constant (but nonetheless allowing for slight increase/decrease).
- For ease of discussion, this description uses the term antimicrobial to denote a broad spectrum activity (e.g. against bacteria and fungi). When speaking of efficacy against a particular microorganism or taxonomic rank, the more focused term will be used (e.g. antifungal to denote efficacy against fungal growth in particular).
- Using the above example, it should be understood that efficacy against fungi does not in any way preclude the possibility that the same antimicrobial composition may demonstrate efficacy against another class of microbes.
- For example, discussion of the strong bacterial efficacy demonstrated by a disclosed embodiment should not be read to exclude that embodiment from also demonstrating antifungal activity. This method of presentation should not be interpreted as limiting the scope of the invention in any way.
- The present invention is directed to a disinfectant formulation. In an aspect of the invention, the disinfectant formulation is in a liquid form. The composition of the disinfectant formulation comprises a biocidal compound and a polymer binder. The composition may further comprise a solvent (such as water or a low molecular weight alcohol), a surfactant, a colorant, a fragrance, among other components.
- A liquid composition is formulated having surface disinfection and residual biocidal properties. The formulation can be applied to a surface by spraying, rolling, fogging, wiping or other means. The formulation acts as a surface disinfectant, killing infectious microbes present on the surface.
- Once dried, the liquid formulation leaves a residual protective film on the surface. The residual film possesses a biocidal property, enabling it to maintain protection of the surface against microbial contamination for an extended time period after its application.
- In a preferred embodiment, the surface disinfectant formulation imparts a film with the capacity to quickly kill bacteria and other germs for at least 24 hours after deposit of the film on the treated surface. In an aspect of the invention, quick kill generally refers to a time period of about 30 seconds to about 5 minutes. The film will remain on the surface and is durable to multiple touches and wearing of the surface.
- In another embodiment of the present invention, the disinfectant formulation is a liquid composition comprising a polymer binder, a biocidal compound, a carrier such as a solvent, and other optional components such as fragrances.
- In an embodiment of the present invention, the disinfectant formulation is a biofilm sealant. The biofilm sealant once applied to a surface forms a polymer film. The polymer film is applied wet and dries as a film layer to lock in and prevent subsequent outgrowth of biofilm microorganisms. The biofilm sealant, although preferably in the form of a liquid, may also take other forms such as a gel, or other form. Once the biofilm sealant is in place, the microbes of the biofilm have limited access to oxygen and exogenous nutrients. The biofilm sealant has the potential to seal in bacteria but also to provide extended release of antimicrobials into the film to kill the microorganisms in the biofilm.
- In an embodiment of the present invention, the biofilm sealant comprises a polymer binder and a biocidal compound. The biocidal compound may include, but is not limited to, any biocidal compound set forth herein.
- In an embodiment of the present invention, the biofilm sealant comprises an oxazoline homopolymer as the polymer binder. The oxazoline homopolymer may have any of the structures as set forth herein.
- In an embodiment of the present invention, the biofilm sealant comprises a polymer binder, a biocidal compound, and an enzyme(s). The enzyme is to assist in degrading the biofilm and provide for enhanced antimicrobial penetration by the biocidal agent and ultimately biofilm removal. Example enzymes include, but are not limited to, proteinase, DNase, RNase, and carbohydrate specific enzymes that can degrade the extracellular matrix associated with the biofilm.
- In an embodiment of the present invention, the biofilm selant comprises a polymer binder and an antibody as a biological material for slow release into the film. The antibody functionality will bind to the biofilm microbe to prevent cross-contamination.
- In an embodiment of the present invention, the biofilm sealant comprises a polymer binder, and a bacteriophage or a mixture of bacteriophages as a biological material for slow release into the film. The bacteriophage act as a targeted antimicrobial agent to kill biofilm associated organisms.
- In an embodiment of the present invention, the biofilm sealant comprises a polymer binder, and a mixture of bacteriophages, antimicrobial agents, enzymes and antibodies as a biological material for slow release into the film.
- In an aspect of the invention, the polymer binder is an oxazoline homopolymer. As another feature of the invention, the oxazoline homopolymer has the following structure:
- wherein
- R1 and R2 are end groups determined by the polymerization techniques used to synthesize oxazoline homopolymer. R1 and R2 are independently selected and include, but are not limited to, hydrogen, alkyl, alkenyl, alkoxy, alkylamino, alkynyl, allyl, amino, anilino, aryl, benzyl, carboxyl, carboxyalkyl, carboxyalkenyl, cyano, glycosyl, halo, hydroxyl, oxazolinium mesylate, oxazolinium tosylate, oxazolinium triflate, silyl oxazolinium, phenolic, polyalkoxy, quaternary ammonium, thiol, or thioether groups. Alternatively, R2 could include a macrocyclic structure formed during synthesis as a consequence of intramolecular attack.
- For example, R1 is a methyl group and R2 is oxazolinium tosylate if methyl tosylate is used as the initiator in the cationic initiated polymerization of oxazoline.
- R3 is an end group determined by the type of oxazoline used in the preparation of the polymer binder of this invention. R3 includes, but is not limited to, hydrogen, alkyl, alkenyl, alkoxy, aryl, benzyl, hydroxyalkyl, or perfluoroalkyl. For example, R3 is an ethyl group if ethyloxazoline is the monomer used to prepare the polymer binder for the present invention.
- n is the degree of oxazoline polymerization in the homopolymer. n is in a range of 1 to 1,000,000. Preferably, n is in a range of 500 to 250,000; most preferably, n is in a range of 2500 to 100,000.
- Similar to oxazoline homopolymer, extended or modified polymers with some variations based on the oxazoline homopolymer are also suitable for the present invention. The techniques and options for performing chemical or molecular structure variations or modifications to oxazoline should be familiar to those skilled in the art. A class of extended or modified polymers based on oxazoline homopolymer can be represented with the following molecular structure:
- wherein
- R1 and R3 have the same definition as those given in the above oxazoline homopolymer.
- B is additional monomer repeating unit linked to oxazoline in a coploymer. The types of arrangement of the repeating units between B and oxazoline in the copolymer can include, but are not limited to, block, alternating, periodic, or combinations thereof. There is no limitation as to the types of B that can be used to copolymerize with or modify the oxazoline of the present invention.
- n is the degree of polymerization for an oxazoline repeating unit; n in the copolymer is in a range of 1 to 1,000,000 and the degree of polymerization for B repeating unit in the copolymer m is in a range of 0 to 500,000 at the same time. Preferably, n is in a range of 500 to 250,000 and m is in a range of 20 to 10,000; and most preferably, n is in a range of 2500 to 100,000 and m is in a range of 50 to 5,000. In addition to linking B to ethyloxazoline through copolymerization, B could also be linked to oxazoline as an end group in a cationic polymerization by using B as a cationic initiator if B itself is already a quaternary ammonium compound.
- Not intended to be all inclusive, B can be, for example, ethyleneimine with the following molecular structure:
- wherein
- R1 and R2 end groups have the same definition as those outlined for oxazoline homopolymer.
- R3 includes, but is not limited to, hydrogen, alkyl, alkenyl, alkoxy, aryl, benzyl, hydroxyalkyl, or perfluoroalkyl.
- R4 includes, but is not limited to, hydrogen, alkyl, alkenyl, alkoxy, aryl, benzyl, hydroxyalkyl, or perfluoroalkyl.
- m is in a range of 0 to 500,000; preferably, in a range of 20 to 10,000; and most preferably, in a range of 50 to 5,000.
- n is in a range of 1 to 1,000,000; preferably, 500 to 250,000; most preferably, in a range of 2500 to 100,000.
- The synthesis of oxazoline and ethyleneimine copolymer can be phased into two steps, for example. In a first step, a cationic ring opening polymerization technique can be used to make polyoxazoline homopolymer. In a second step, the polyoxazoline made in the first step can be hydrolyzed to convert part of polyoxazoline repeating units into polyethyleneimine. Alternatively, oxazoline-ethylenimine copolymer can be made with the appropriate respective monomers, an oxazoline and an aziridine. The result would be a cationic polymer having the above structure.
- The degree of polymerization for oxazoline repeating unit n in the copolymer is in a range of 1 to 1,000,000 and the degree of polymerization for ethyleneimine repeating unit in the copolymer m is in a range of 0 to 500,000 at the same time. Preferably, n is in a range of 500 to 250,000 and m is in a range of 20 to 10,000, and most preferably n is in a range of 2500 to 100,000 and m is in a range of 50 to 5,000.
- Alternatively, the nitrogen in the ethyleneimine repeating unit could be further quaternized to generate the following cationic copolymer:
- Any quaternization technique that is familiar to those skilled in the art could be used to quaternize the polymer of this example. R1, R2, R3 and R4 have the same meaning as those designated in the above oxazoline-ethyleneimine copolymer. R5 includes, but is not limited to, a hydrogen, methyl, ethyl, propyl, or other types of alkyl group. The corresponding anion X− is a halogen, sulfonate, sulfate, phosphonate, phosphate, carbonate/bicarbonate, hydroxy, or carboxylate.
- The ranges for n and m are also the same as those described in oxazoline-ethyleneimine copolymer.
- Another example of B that can be used for the present invention is polydiallyldimethylammonium chloride. Polyethyloxazoline modified with polydiallyldimethylammonium chloride has the following structure:
- wherein
- R1 and R4 have the same meaning as described in previous example for quaternized oxazoline-ethyleneimine copolymer.
- R2 and R3, independently, include, but are not limited to, short chain alkyl groups such as C1 to C6. The corresponding anion X− is a halogen, sulfonate, sulfate, phosphonate, phosphate, carbonate/bicarbonate, hydroxy, or carboxylate.
- n and m are defined and numbered the same as in previous examples.
- B could be other olefins including, but not limited to, diallyldimethylammonium chloride, styrene, methoxystyrene, and methoxyethene. Ethyloxazoline can also be copolymerized with heterocyclic monomers such as oxirane, thietane, 1,3-dioxepane, oxetan-2-one, and tetrahydrofuran to enhance the performance of the polymer for the present invention. The binder used in this invention could also employ pendant oxazoline groups on a polymer backbone, such as an acrylic or styrene based polymer, or a copolymer containing acrylic or styrene.
- Examples of commercially available polyethyloxazolines include, but are not limited to, Aquazol 500 from Polymer Chemistry Innovations, Inc.
- The amount of polymer binder that can be used in the liquid formulation can vary somewhat depending upon desired length of residual activity of the composition and the nature of all the other components in the composition. Preferably, the amount of polymer binder in the liquid formulation is in a range of 0.1% to 20% based on the weight of liquid formulation. In a liquid formulation for healthcare applications, the amount of polymer binder in the liquid formulation is more preferably in a range of 0.5% to 10%, and most preferably in a range of 0.8% to 5%. In liquid formulations for all-purpose and bathroom cleaners, the amount of polymer binder in the liquid formulation is more preferably in a range of 0.1% to 10%, and most preferably in a range of 0.1% to 5%.
- The polymer binder preferably is water-soluble and can be readily removed from surface if any buildup is noticed. Present in small amounts, it nonetheless can provide a durable bond between biocidal compound and the treated surface to facilitate residual efficacy.
- The biocidal compound may be a quaternary ammonium compound (QAC) with the following molecular structure:
- wherein
- R1, R2, R3, and R4 are independently selected and include, but are not limited to, alkyl, alkoxy, or aryl, either with or without heteroatoms, or saturated or non-saturated. Some or all of the functional groups may be the same.
- The corresponding anion X− includes, but is not limited to, a halogen, sulfonate, sulfate, phosphonate, phosphate, carbonate/bicarbonate, hydroxy, or carboxylate.
- QACs include, but are not limited to, n-alkyl dimethyl benzyl ammonium chloride, di-n-octyl dimethyl ammonium chloride, dodecyl dimethyl ammonium chloride, n-alkyl dimethyl benzyl ammonium saccharinate, and 3-(trimethoxysilyl) propyldimethyloctadecyl ammonium chloride.
- Combinations of monomeric QACs are preferred to be used for the invention. A specific example of QAC combination is N-alkyl dimethyl benzyl ammonium chloride (40%); N-octyl decyl dimethyl ammonium chloride (30%); di-n-decyl dimethyl ammonium chloride (15%); and di-n-dioctyl dimethyl ammonium chloride (15%). The percentage is the weight percentage of individual QAC based on the total weight of blended QACs composition.
- Polymeric version of the QACs with the following structures can also be used for the invention.
- wherein
- R1, R2, R5, and R6, independently, include, but are not limited to, hydrogen, methyl, ethyl, propyl or other longer carbon alkyl groups.
- R3 and R4 are independently selected and include, but are not limited to, methylene, ethylene, propylene or other longer alkylene linking groups.
- n is the degree of polymerization; n is an integer in a range of from 2 to 10,000.
- Examples of cationic polymers with the above structure, include but are not limited to, polyamines derived from dimethylamine and epichlorohydrin such as Superfloc C-572 commercially available from Kemira Chemicals.
- Still another polymeric QAC suitable for the invention is poly diallyldimethylammonium chloride or polyDADMAC.
- Yet another class of QACs useful for the present invention are those chemical compounds with biguanide moiety in the molecule. Examples of this class of cationic antimicrobials include, but are not limited to, PHMB and chlorhexidine.
- Examples of commercially available quaternary ammonium compounds include, but are not limited to, Bardac 205M and 208M from Lonza, and BTC885 from Stepan Company.
- The biocidal compound may be a weak acid, which has been shown to be particularly effective in bathroom cleaners. In these type of products, citric, sulfamic (also known as amidosulfonic acid, amidosulfuric acid, aminosulfonic acid, and sulfamidic acid), glycolic, lactic, lauric and capric acids are useful as both an effective biocide and a cleaning agent for soap scum and hard wart deposits.
- Other compounds which may be useful are silane quaternary salts such as 3(trihydroxysilyl)propyldimethyloctadecyl ammonium chloride. These may have the added benefit of reacting to the surface being treated for an enhancement of the residual properties.
- Further biocidal compounds suitable for use in the present liquid formulation span a broad range of antimicrobials, biocides, sanitizers, and disinfectants. A water soluble or dispersible biocidal compound is preferred, although biocides soluble in alcohol may be alternatively employed.
- A non-exhaustive list of biocidal compounds suitable for use in the present formulation include triclosan, zinc pyrithione, metal salts and oxides, phenols, botanicals, halogens, peroxides, heterocyclic antimicrobials, aldehydes, and alcohols.
- The concentration of biocidal compound in the formulation can be in a range of 0.05% to 20% based on the weight of the liquid composition. For a liquid formulation for a healthcare application, preferably in a range of 0.1% to 20%, and more preferably in a range of 0.5% to 3%. For a liquid formulation for all-purpose and bathroom cleaners, preferably in a range of 0.05% to 10%. For a formulation for a protectant, preferably in a range of 0.05% to 2%.
- The carrier or media for the liquid formulation of this invention can be any solvent that is volatile and allow easy evaporation at ambient condition. Examples of liquid carriers include, but are not limited to, water and low molecular weight alcohols such as C1 to C8 alkanols. Specific examples include, but are not limited to, ethanol, isopropyl alcohol, butanol, pentanol, and combinations thereof.
- Another class of solvents for use in the invention includes alkylene glycol ether. Examples include, but are not limited to, ethylene glycol monopropyl ether, ethylene glycol monobutyl ether, ethylene glycol monohexyl ether, ethylene clycol monohexyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monobutyl ether, diethylene glycol monohexyl ether, triethylene glycol monomethyl ether, triethylene glycol monoethyl ether, triethylene glycol monobutyl ether, propylene glycol methyl ether, propylene glycol methyl ether acetate, propylene glycol n-butyl ether, dipropylene glycol n-butyl ether, dipropylene glycol methyl ether, dipropylene glycol methyl ether acetate, propylene glycol n-propyl ether, dipropylene glycol n-propyl ether, and tripropylene glycol methyl ether.
- Another class of solvents for use in the invention is based on terpenes and their derivatives such as terpene alcohols, terpene esters, terpene ethers, or terpene aldehydes. Examples of solvents, include but are not limited to, pine oil, lemon oil, limonene, pinene, cymene, myrcene, fenchone, borneol, nopol, cineole, ionone and the like.
- A preferred carrier in a liquid formulation for a home care cleaning application is water.
- If the method of the application of the liquid formulation of the present invention is pressurized aerosol, a propellant may be needed in the composition. A variety of propellants or mixtures can be used for the present invention and should be familiar to those skilled in the art. C1 to C10 hydrocarbons or halogenated hydrocarbons are typical propellants in aerosol compositions known to the industry. Examples of such propellants include, but are not limited to, pentane, butane, propane, and methane. Other types of propellants that can be used for the present invention also include compressed air, nitrogen, or carbon dioxide. Alternatively, a bag on valve package may be used to aerosol the product without directly add a propellant to the composition.
- Either a single solvent or a mixture of the above solvents can be used for the present invention. The types of solvents used for the present invention may depend upon the intended uses of the residual disinfectant composition. For example, if the composition of the present invent is intended for home care use, cleaning the contaminated surfaces free of all types of dirt or soil may be of primary interest. Liquid carrier or media that assist and enhance the removal of soil may be formulation of the invention. For example, the residual disinfectant formulation or composition of the present invention may desire to include alkyl or multi-alkyl glycol ethers for better cleaning performance in the home care version of the formulation of the present invention. On the other hand, if the primary goal of the residual disinfectant composition is to be used at a health care facility where the major concern is hospital acquired infection, then quick drying of the liquid composition of the present invention may be more desirable than cleaning dirt or soil out of the surfaces. Low molecular weight alcohols should be considered to help the liquid formulation of the present invent dry fast after the application. Also, a low molecular weight alcohol in the liquid formulation will strengthen the sanitizing activity of the liquid composition.
- For health care use of the residual disinfectant, a mixture of water and low molecular weight alcohol is preferred. The amount of alcohol present in the liquid formulation is preferred to be at such a level that the liquid formulation is capable of forming a zerotropic mixture between the alcohol and water. A minimum amount of alcohol, if present, in the liquid composition is 10%. Preferably, for health care use of the residual disinfectant, the alcohol concentration is 30%, and most preferably the alcohol concentration is at least 50% based on the weight of liquid formulation for the health care use of the composition of the invention.
- A surfactant or wetting agent may be employed. The surfactant assists the liquid formulation to spread and evenly coat the surface being treated. The surfactant additionally contributes to the formation of a zeotropic mixture between alcohol and water, thus facilitating a rapid and uniform drying of the liquid formulation once being applied onto surface. A surfactant also plays an important role in the residual disinfectant liquid formulation of the present invention for home care use if the soil cleaning performance is the key feature the product is designed to possess.
- Surfactants appropriate for the present liquid formulation include, but are not limited to, those that are nonionic, anionic, or amphoteric in nature. Examples of commercially available wetting agents include, but are not limited to, Ecosurf SA-4 or Tergitol TMN-3 from Dow Chemical, and Q2-5211 from Dow Corning.
- An amine oxide surfactant is preferred especially when the QAC is used as the biocidal compound in the formulation.
- In the category of nonionic surfactants, ethoxylated alcohols with different amounts of ethylene oxides or HLB values can be used. Examples of ethoxylated alcohols include, but are not limited to, Triton X-100 (Dow Chemical, Midland, Mich.), Ecosurf EH nonionic surfactant series from Dow Chemical, Tergitol nonionic surfactant series from Dow Chemical, the Surfonic surfactant series from Huntsman Corp., the Neodol surfactant series from Shell, the Ethox surfactant series from Ethox Chemicals and the Tomadol surfactant series from Air Products and Chemicals, Inc.
- Another class of nonionic surfactants include alkylpolyglucosides. Examples include the Glucopon Series from BASF and the Ecoteric series from Huntsman.
- An alternative class of surfactants that is preferred for the liquid formulation are silane-based surfactants. Examples include but, are not limited to, silicone polyethers organofunctional or reactive silane wetting agents, and fluorochemical based wetting agents.
- The content of the surfactant in the liquid formulation is in a range of 0% to 10%, preferably in a range of 0.01% to 5%.
- Depending on the targeted uses, a liquid formulation of the present invention for home care use may need appropriate pH condition. For example, if the liquid product is used in the kitchen area, a high pH product may be desired in order to effectively remove grease soils commonly found in the area. If the product is used in bathroom area, soap scum and hard water deposits may be the primary concern. In such case, a low pH product may be more appropriate for such a purpose. There is no limitation on the types of pH adjusting agents that can be added into the liquid composition of the present invention. Example of pH adjusting agents that can be used include, but are not limited to, triethanolamine, diethanolamine, monoethanolamine, sodium hydroxide, sodium carbonate, potassium hydroxide, potassium carbonate, calcium carbonate, citric acid, acetic acid, hydrochloric acid, sulfamic acid, sulfuric acid and the like.
- Other than components mentioned above, additional functional components may be included in the liquid composition of the present invention. Additional components include, but are not limited to, chelants, compatibilizers, coupling agents, corrosion inhibitors, rheology modifiers, fragrances, colorants, preservatives, UV stabilizers, optical brighteners, and active ingredient indicators.
- In an embodiment of the present invention, the liquid solution comprises a polymer binder, a quaternary ammonium compound, a silicone-based surfactant, and ethanol. The liquid formulation can be made or mixed by any conventional method known to one of ordinary skill in the art. There are no preferred addition procedures for the formulation of the present invention provided that the formulation is ultimately homogeneous, compatible and stable. For example, if the polymer binder is a solid, it may be preferable to first dissolve or disperse the polymer in a carrier such as water or alcohol to make a stock polymer binder liquid dispersion. The stock polymer binder liquid dispersion may be readily added into the formulation of the present invention during the mixing procedure.
- The liquid formulation may be applied by a variety of means. If sprayed, the liquid formulation advantageously may be supplied in a conventional bottle with a sprayer. The sprayer can be a trigger sprayer. As an option to a trigger sprayer, an aerosol can also be used to deliver the liquid formulation on to surfaces. Additional application means include, but are not limited to, fogging, rolling, brushing, mopping, and using a wipe by a variety of application devices. It is within the scope of the present invention that wipe products can also be made comprising or pre-treated with the disinfectant formulation(s) of the present invention, for example, for off-the-shelf sale or use.
- In an embodiment of the invention, a wipe is provided having up to 24-hour residual sanitization activity. The wipe is capable of protecting a hard surface from microbial growth and protection against bacteria without leaving a significant residue or build-up.
- In an embodiment of the invention, the wipe is comprised of a substrate and a formulation applied on the substrate or present in the substrate of the wipe.
- The wipe formulation provides a solid transparent film water soluble enough to be easily removed with additional cleanings yet durable enough to remain on the surface even after being touched.
- The substrate is any fibrous material capable of absorbing and/or adsorbing water, preferably at least three times its weight in water. The substrate comprises a synthetic material, a natural material, or a combination thereof. Examples of synthetic materials include, but are not limited to, polypropylene, polystyrene, polyester, nylon, rayon, acrylic, spandex, and a combination thereof. Examples of natural materials include, but are not limited to, cotton, linen, silk, wool, hemp, flax, and a combination thereof.
- The substrate may be woven or non-woven. A non-woven substrate may be made by any number of manufacturing methods. The resulting non-woven substrate may be, but is not limited to, melt-blown, coformed, spunbonded, airlaid, hydroentangled, spunlaced, bonded, carded, laminated, or a combination thereof. For example, a substrate may comprise a melt-blown polymeric material.
- In an embodiment of the invention, the wipe formulation comprises a biocidal compound, a polymer binder and a wetting agent/surfactant.
- For a substrate comprising a natural material, the wipe formulation may comprise a cationic containing compound that is designed to compete with the quaternary ammonium compound(s) for anionic species sites on the substrate. Salts with high ionic strengths can also be used. Examples of salts for use in the wipe formulation include, but are not limited to, potassium citrate, sodium citrate, magnesium sulphate, sodium chloride, ammonium chloride, potassium chloride, and a combination thereof
- The wipe formulation provides initial disinfection then once dried leaves a residual protective film on the surface. The film possesses biocidal properties with the ability to kill bacteria, for example, within a 5-minute contact time for up to 24 hours after initial application.
- In a preferred embodiment, the wipe formulation comprises a poly(2-ethyl-2-oxazoline), a quaternary ammonium compound or combination of quaternary ammonium compounds, an alcohol ethoxylate, water, and an optional fragrance.
- Quaternary ammonium compounds (QAC) are especially suited for this wipe application as they provide protection against a broad range of microorganisms. Examples of such compounds are commercially available from Stepan Chemical under the trade name BTC885. BTC885 contains 50% of a blend of quaternary ammonium compounds. A similar material is also commercially available from Lonza under the trade name Bardac 205M.
- Preferably, the quaternary ammonium compound and the binder are in a ratio of quaternary ammonium compound to binder of 1:4 to 1:1.
- Preferably, the wipe formulation comprises a poly(2-ethyl-2-oxazoline) in an amount of 1 weight % to 5 weight %, wherein the weight percentage is based on the total weight of the wipe formulation.
- Preferably, the wipe formulation comprises a quaternary ammonium compound in an amount of at least 0.2 weight percent, preferably 0.2 weight percent to 2 weight percent, wherein the weight percentage is based on the total weight of the wipe formulation.
- Preferably, the wipe formulation comprises a nonionic surfactant.
- In an embodiment of the invention, the nonionic surfactant is an alcohol ethoxylate. Preferably, the wipe formulation comprises the alcohol ethoxylate in an amount of 0.05 weight % to 0.5 weight %, wherein the weight percentage is based on the total weight of the wipe formulation. A preferred alcohol ethoxylate is a linear alcohol ethoxylate with at least 9 moles of ethylene oxide, more preferably with at least 12 moles of ethylene oxide. It is unexpected that an alcohol ethoxylate, such as in this group, when used in the formulation of the present invention surprisingly and favorably contributes to the aesthetics of the resulting film by drying to a hard transparent film (as opposed to a tacky, hazy film) yet remains water soluble enough to allow release of the quaternary ammonium compound(s) for antimicrobial efficacy.
- A weak acid including, but not limited to, citric acid, lactic acid, sulfamic, acid, glycolic acid, or a combination thereof can be added to the formulation to increase efficacy against gram negative bacteria and aid in hard water stain or soap scum soil removal.
- Ethylenediaminetetraacetic acid, disodium salt or EDTA disodium salt can be added to the formulation to increase antimicrobial efficacy in the presence of hard water.
- The wipe formulation optionally comprises a fragrance. If a fragrance is present, the wipe formulation preferably comprises a fragrance in an amount of 0 weight % to 0.5 weight %, wherein the weight percentage is based on the total weight of the wipe formulation.
- Water is a suitable carrier for inert and active materials. Solvents such as ethanol or isopropanol are optionally added to decrease drying time.
- The wipe formulation of the present invention is effective for the above purposes without requiring other components to be present in the formulation, although other components may be present. For example, the wipe formulation of the present invention is effective for its residual sanitization activity without hydrogen peroxide as a component of the formulation.
- To disinfect a contaminated surface, spray the liquid formulation until the area is completely covered. The wet formulation subsequently may be wiped dry with a dry cloth or paper towel.
- The invention also relates to an article treated with a disinfectant formulation in accordance with aspects of the invention.
- The following examples illustrate liquid formulations made in accordance with aspects of the present invention. The testing results on these formulations demonstrate the desired residual sanitizing or disinfecting performance once being applied onto surfaces and dried. Cleaning performance is also tested on those formulations that not only provide residual disinfecting benefit but also cleaning features.
- Formulations were tested for residual efficacy using the EPA 01-1A protocol. Briefly, bacteria were added to a glass slide and allowed to dry on the surface. The formulation was then sprayed onto the surface and dried to form a transparent film. Once a film had formed, the glass slide was exposed to alternating wet and dry cycles using the Gardner wear tester as described in the protocol. In between each cycle the slide was re-inoculated with bacteria. After the appropriate number of wear and re-inoculations (48 passes and 11 re-inoculations for healthcare formulation and 24 passes 5 re-inoculation for homecare formulation) the slide was exposed to bacteria for the indicated time frame (i.e. 5 minutes) followed by recovery in an appropriate neutralizing solution.
- In addition to residual efficacy, initial efficacy of the composition of the present invention was also tested according to ASTM E 1153.
- A modified ASTM D4488 was used to evaluate the hard surface cleaning performance for the home care composition of the present invention. A soil of the following composition was used for the evaluation.
-
TABLE 1 Weight percentage of each Components component (%) Pure vegetable oil 75 TM-122 AATCC carpet soil 25 *TM-122 AATCC carpet soil was obtained from Textile Innovators - In the process of making a soiled ceramic tile for the cleaning test, around 2 grams of the liquid soil was placed on an aluminum foil. A roller was used to roll and spread out the soil on the foil and let the roller pick up the soil as much as possible. The soil on the roller was transferred to the glazed surface of a ceramic tile evenly by rolling the soiled roll on the ceramic surface. The soiled ceramic tile was then baked in oven set at 180C for 45 minutes. The baked tile was conditioned at room temperature for 24 hours before being used for the cleaning test.
- A Gardner wear tester was used in the cleaning test. Scouring pads of around 1 cm width were attached to the abrasion boat for the wearing. Around 4 grams of test formulation was placed in a weighing boat. The attached scouring pad was dipped into the weighing boat to pick up the testing formulation.
- The cleaning process started immediately after the pad is wetted with the cleaning formulation. Seven wearing cycles (back and forth) were used in the test.
- The following formulation in the example uses alcohol as the major carrier in order to provide fast drying property to the liquid formulations.
-
TABLE 2 HE1 HE2 HE3 Components (wt %) (wt %) (wt %) Water balance balance balance Ethanol 70 70 0 2-Propanol 0 0 70 Polyethyloxazoline 2 2 2 Quaternary 0.8 1.2 1.2 ammonium compound Wetting 0.1 0.1 0.1 agent/Surfactant - The residual efficacy testing was conducted using EP01-1A protocol and the results are listed in the following Table.
-
TABLE 3 EP01-1A (average log reduction Formulation bacterial) HE1 3.53 HE2 5.50 HE3 4.50 - These formulations show excellent residual efficacy result based on EP01-1A test.
- The ASTM E 1153 test protocol was also followed to assess the initial biocidal property of HE2. Test results are presented in the following table.
-
TABLE 4 Initial Efficacy Time Method Complete kill (<10 Bacterial 3 log reduction CFU/PFU) Klebsiella pneumoniae 30 seconds 1 minute ASTM E 1153 Pseudomonas 30 seconds 30 seconds ASTM E 1153 aerugniosa Staphylococcus aureus 30 seconds 30 seconds ASTM E 1153 MRSA 30 seconds 30 seconds ASTM E 1153 VRE 30 seconds 30 seconds ASTM E 1153 Enterobacter 30 seconds 30 seconds ASTM E 1153 aerogenes Enterococcus faecalis 30 seconds 1 minute ASTM E 1153 Fungal Aspergillus niger 1 minute 5 minutes ASTM E 1153 Tricophyton mentagrophytes 1 minute 5 minutes ASTM E 1153 Viral H1N1 (envelope) 30 seconds 30 seconds ASTM E 1053 MS2 (Non-enveloped) 30 seconds 5 minutes ASTM E 1053 Time frame of Residual Efficacy exposure Log reduction Method Pseudomonas 5 minutes >3 EPA 01-1A aerugniosa Enterobacter 5 minutes >3 EPA 01-1A aerogenes Staphylococcus aureus 5 minutes >3 EPA 01-1A - These data clearly demonstrate that sample surfaces treated with the exemplary liquid formulation disclosed herein possess a demonstrable biocidal activity at the indicated time frame.
- These compositions are formulated using water as the carrier. They are intended for homecare use where VOC regulations prohibit most use of high levels of organic solvents such as alcohols.
-
TABLE 5 H1 H2 H3 H4 H5 Components (wt %) (wt %) (wt %) (wt %) (wt %) Water balance balance balance balance balance EDTA tetra sodium 0 0 0 0 0.4 Polyethyloxazoline 1 1 1 0.5 0.5 Ethoxylated alcohol 0.33 0 0 0 0 #1 Ethoxylated alcohol 0 0 0.2 0.2 0.2 #2 Quaternary 0.4 0.4 0.4 0.4 0.4 ammonium compound Ethanolamine 0.2 0.2 0.2 0.2 0.2 Wetting Agent 0.1 0.1 0.1 0.1 0.1 - The residual efficacy of these formulations were assessed using EP01-1A protocol and the results are listed in the following Table.
-
TABLE 6 EP01-1A (average log reduction Formulation bacterial) H1 3.53 H2 5.50 H3 5.50 H4 4.90 H5 3.80 - Enterobacter aerogenes was the bacterial for H1 testing and Staphylococcus aureus was the bacteria used in the testing for the rest of the formulations.
- The testing results demonstrate that the H1 to H5 all provide residual efficacy to the treated surfaces. The cleaning performance was also evaluated using the modified ASTM D4488 test method.
- The testing results also clearly visually showed the formulation of present invention not only provided residual efficacy against bacterial but also good cleaning performance on soiled surfaces.
- Additional formulations set forth in the Tables below were tested for home care and home cleaning applications. To solubilize the fragrance, a pre-mix is prepared containing the fragrance, quaternary ammonium compound, surfactant and glycol ether if present.
-
TABLE 7 Light Duty Protectant Formulations P1 P2 P3 P4 P5 P6 P7 P8 Component (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) Polyethyloxazoline 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 Quaternary 0.40 0.40 0.40 0.40 0.40 0.40 0.40 0.40 ammonium compound Fragrance 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 Wetting agent 0.30 Amine Oxide 0.30 0.30 0.30 0.30 Ethoxylated 0.30 Cationic surfactant Dicoco quat 0.30 Ethoxylated 0.30 alcohol Triethanolamine 0.50 NaEDTA 0.10 Sodium 0.10 metasilicate pentahydrate Sodium Carbonate Water* B B B B B B B B P9 P10 P11 P12 P13 P14 P15 Component (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) Polyethyloxazoline 1.00 1.00 0.50 1.00 0.50 1.00 0.50 Quaternary 0.40 0.40 0.40 0.20 0.20 0.10 0.10 ammonium compound Fragrance 0.05 0.05 0.05 0.05 0.05 0.05 0.05 Wetting agent 0.10 0.10 0.10 0.10 0.10 0.10 Amine Oxide 0.30 Ethoxylated Cationic surfactant Dicoco quat Ethoxylated alcohol Triethanolamine 0.50 0.50 0.50 0.50 0.50 0.50 NaEDTA Sodium metasilicate pentahydrate Sodium 0.10 Carbonate Water* B B B B B B B P16 P17 P18 P19 P20 P21 P22 P23 Component (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) Polyethyloxazoline 1.00 0.50 1.00 0.50 1.00 0.50 1.00 0.50 Quaternary 0.20 0.20 0.10 0.10 0.20 0.20 0.10 0.10 ammonium compound Fragrance 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 Wetting agent Amine Oxide 0.30 0.30 0.30 0.30 Ethoxylated Cationic surfactant Dicoco quat Ethoxylated 0.20 0.20 0.20 0.20 alcohol Triethanolamine 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 NaEDTA Sodium metasilicate pentahydrate Sodium Carbonate Water* B B B B B B B B P24 P25 P26 P27 P28 P29 Component (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) Polyethyloxazoline 1.00 1.00 1.00 0.50 0.50 0.50 Quaternary 0.20 0.20 0.20 0.20 0.20 0.20 ammonium compound Fragrance 0.05 0.05 0.05 0.05 0.05 0.05 Wetting agent Amine Oxide Ethoxylated Cationic surfactant Dicoco quat Ethoxylated 0.20 0.20 0.20 0.20 0.20 0.20 alcohol Triethanolamine NaEDTA 0.10 0.10 Sodium 0.10 0.10 metasilicate pentahydrate Sodium 0.10 0.10 Carbonate Water* B B B B B B *B means balance water -
TABLE 8 All Purpose Cleaner Formulations A1 A2 A3 A4 A5 A6 A7 A8 Component (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) Polyethyloxazoline 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 Quaternary 0.40 0.40 0.40 0.40 0.40 0.40 0.40 0.40 ammonium compound Fragrance 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 Amine Oxide 0.90 0.90 0.90 0.90 0.90 0.90 0.90 Ethoxylated 0.50 Alcohol 1 Ethoxylated Alcohol 2 Alkyl- polyglucoside Triethanolamine 1.0 Glycol Ether 1 Glycol Ether 2 NaEDTA 0.40 Sodium 0.10 metasilicate pentahydrate Sodium 0.10 Carbonate STPP 0.10 TKPP 0.10 Water* B B B B B B B B A9 A10 A11 A12 A13 A14 A15 Component (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) Polyethyloxazoline 1.00 1.00 1.00 1.20 1.00 1.20 1.00 Quaternary 0.40 0.40 0.50 0.50 0.40 0.80 0.40 ammonium compound Fragrance 0.10 0.10 0.10 0.10 0.10 0.10 0.10 Amine Oxide 0.60 0.45 0.45 0.60 0.60 0.60 0.45 Ethoxylated Alcohol 1 Ethoxylated Alcohol 2 Alkyl- polyglucoside Triethanolamine Glycol Ether 1 5.00 Glycol Ether 2 NaEDTA Sodium 0.25 0.25 0.25 0.10 0.10 0.10 0.10 metasilicate pentahydrate Sodium Carbonate STPP TKPP Water* B B B B B B B A16 A17 A18 A19 A20 A21 A22 A23 A24 Component (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) Polyethyloxazoline 1.0 0.80 0.80 1.0 1.00 1.20 1.00 1.00 1.00 Quaternary 0.80 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 ammonium compound Fragrance 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 Amine Oxide 0.60 0.60 0.60 1.50 1.20 0.60 Ethoxylated 0.10 Alcohol 1 Ethoxylated 0.10 Alcohol 2 Alkyl- 0.60 0.50 0.50 polyglucoside Triethanolamine 0.50 Glycol Ether 1 5.00 Glycol Ether 2 NaEDTA Sodium 0.10 0.10 0.05 0.05 0.05 metasilicate pentahydrate Sodium Carbonate STPP TKPP Water* B B B B B B B B B A25 A26 A27 A28 A29 A30 A31 A32 Component (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) Polyethyloxazoline 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 Quaternary 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 ammonium compound Fragrance 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 Amine Oxide 0.60 Ethoxylated 0.20 0.60 0.60 0.80 Alcohol 1 Ethoxylated 0.20 0.20 0.80 Alcohol 2 Alkyl- 0.40 0.40 0.40 polyglucoside Triethanolamine 0.50 0.50 0.50 0.50 0.50 0.50 Glycol Ether 1 2.40 2.40 Glycol Ether 2 2.40 2.40 2.40 NaEDTA Sodium 0.05 0.05 metasilicate pentahydrate Sodium Carbonate STPP TKPP Water* B B B B B B B B -
TABLE 9 Bathroom Cleaner Formulations B1 B2 B3 B4 B5 B6 B7 B8 Component (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) Polyethyloxazoline 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 Quaternary 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 ammonium compound Fragrance 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 Amine Oxide 0.84 0.42 0.84 0.42 0.84 Ethoxylated 0.84 0.84 0.84 alcohol 1 Ethoxylated 0.50 0.50 alcohol 2 Glycol Ether 4.00 4.00 4.00 NaEDTA 2.90 2.90 2.90 2.90 2.90 2.90 Citric Acid 2.50 2.50 Sulfamic Acid Water* B B B B B B B B B9 B10 B11 B12 B13 B14 B15 Component (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) Polyethyloxazoline 1.00 1.00 1.00 1.00 1.00 1.00 1.00 Quaternary 0.20 0.20 0.20 0.20 0.20 0.20 0.20 ammonium compound Fragrance 0.10 0.10 0.10 0.10 0.10 0.10 0.10 Amine Oxide 0.42 0.84 0.42 0.84 0.42 Ethoxylated 0.84 0.84 alcohol 1 Ethoxylated 0.50 0.50 0.50 alcohol 2 Glycol Ether 4.00 4.00 4.00 4.00 4.00 4.00 NaEDTA Citric Acid 2.50 2.50 2.50 2.50 Sulfamic Acid 2.50 2.50 2.50 Water* B B B B B B B B16 B17 B18 B19 B20 B21 B22 B23 B24 Component (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) Polyethyloxazoline 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 Quaternary 0.80 0.80 0.80 0.80 0.80 0.80 0.80 0.80 0.80 ammonium compound Fragrance 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 Amine Oxide 0.80 0.40 0.80 0.40 0.80 0.40 Ethoxylated 0.80 0.80 0.80 alcohol 1 Ethoxylated 0.50 0.50 0.50 alcohol 2 4.0 4.0 4.0 4.0 Glycol Ether NaEDTA Citric Acid 2.50 2.50 2.50 2.50 2.50 2.50 Sulfamic Acid 2.50 2.50 2.50 Water* B B B B B B B B B - A concentrate of a water based formulation is prepared by removing a portion of the water from the formulation, concentrating the remaining raw materials. The resulting concentrate can then be diluted back to use strength prior to use. The 5 times and 10 times concentrates are typically used in the janitorial and sanitization supply industries with customers in the hospitality area. Concentrates can be prepared at 15 times, 20 times, or even higher levels, as desired, and still be within the scope of the present invention. Concentrates are desirable in these industries as it reduces shipping costs and conserves storage space. Table 10 illustrates example concentrate formulations in an embodiment of the invention.
-
TABLE 10 Concentrate Formulations All All All Purpose Purpose Purpose Bathroom Bathroom Bathroom Protectant Protectant Protectant Cleaner Cleaner Cleaner Cleaner Cleaner Cleaner Component 5X 10X 20X 5X 10X 20X 5X 10X 20X Polyethyloxazoline 5.0 10 20 5.0 10 20 5.0 10 20 Quaternary 1.0 2.0 4 2.5 5.0 10 1.6 3.2 6.4 ammonium compound Fragrance 0.25 0.50 1.0 0.5 1.0 2.0 0.75 1.5 3.0 Surfactant 0.50 1.0 2.0 4.0 8.0 16 3.0 6.0 12 Glycol 12.5 25 50 Ether TEA 2.5 5.0 10 Citric Acid 12.5 25 50 Water* B B B B B B B B B - Multiple polymeric compounds were tested for the capability to provide persistent bioburden reduction utilizing the EPA 01-1A protocol against Enterobacter aerogenes. 50 microL of each formulation was allowed to dry on glass carriers before being subjected to the test. Each test was conducted in the presence of 5% FBS. As noted in Table 11, the combination of polyoxazoline and quaternary ammonium provided a synergistic residual sanitizing benefit.
-
TABLE 11 Formula 1 Formula 2 Formula 3 Formula 4 Formula 5 Active Quaternary Quaternary Quaternary Quaternary Quaternary Ingredient Ammonium Ammonium Ammonium Ammonium Ammonium Blend blend blend blend blend Polymer 3 Glycidoxypropyl- Trimethoxysilyl- acrylic polyamide polyoxazoline trimethoxysilane propyl emulsion resin (Polyethyleneimine) SSP-060 Aesthetics hazy film tacky film when dry clear, non- clear, non- clear, non- tacky film tacky film tacky film Associated NT* NT* 0.5 log 1.8 log 5 log Log Reduction reduction reduction reduction *indicates not tested (NT) due to poor aesthetics - Wipe formulations A-I were prepared and tested on various substrates.
- In the tests for Formulations A-F, 8 grams of formulation was added to a 7″×8″, 100% PP, 34 gram per square meter substrate. The substrate, which was obtained from Rockline Industries, was a Kimberly Clark melt blown product. The results are shown in Table 12 below.
-
TABLE 12 A B C D E F (wt %) (wt %) (wt %) (wt %) (wt %) (wt %) Aquazol 500 1.50 1.50 1.50 0.60 0.90 1.20 BTC 885 0.45 0.90 1.43 1.00 1.00 1.00 (50% Active) Tomadol 25-12 0.20 0.20 0.20 0.20 0.20 0.20 Fragrance 0.10 0.10 0.10 0.10 0.10 0.10 Water balance balance balance balance balance balance Log 2.4 3.9 4.7 <0.5 2.8 3.2 Reduction* Result* Fail Pass Pass Fail Fail Pass *Clorox method 01-1A results - The method was adapted to wipes by folding the substrate lengthwise into 1″ folds then wrapping the folded substrate strip across the second, third and fourth fingers. One pass was made across the glass carriers. A log reduction greater than 3.0 was required to be considered passing. - In each of the tests for Formulations G and H, 11 grams of a formulation was added to a 7″×8″ 100% polyester substrate from US Nonwovens (Item # XNW-8045). The results are shown in Table 13 below.
-
TABLE 13 G H (wt %) (wt %) Aquazol 500 1.50 1.50 BTC 885 1.00 1.40 (50% Active) Tomadol 25-12 0.20 0.20 Fragrance 0.10 0.10 Water balance balance Log Reduction* 2.2 4.1 Result* Fail Pass *Clorox method 01-1A results-The method was adapted to wipes by folding the substrate lengthwise into 1″ folds then wrapping the folded substrate strip across the second, third and fourth fingers. One pass was made across the glass carriers. A log reduction greater than 3.0 was required to be considered passing. - In tests for Formulation I, 8 grams of the formulation was added to a 7″8″, 100% polypropylene (PP), 35 grams per square meter substrate. The substrate was from Diamond wipes (Item # P50535). The results are shown in Table 14 below.
-
TABLE 14 I (wt %) Aquazol 500 1.50 BTC 885 0.90 (50% Active) Tomadol 25-12 0.20 Fragrance 0.10 Water balance Log Reduction* 4.3 Result* Pass *Clorox method 01-1A results-The method was adapted to wipes by folding the substrate lengthwise into 1″ folds then wrapping the folded substrate strip across the second, third and fourth fingers. One pass was made across the glass carriers. A log reduction greater than 3.0 was required to be considered passing. - It will therefore be readily understood by those persons skilled in the art that the present composition and methods are susceptible of broad utility and application. Many embodiments and adaptations other than those herein described, as well as many variations, modifications and equivalent arrangements, will be apparent from or reasonably suggested to one of ordinary skill by the present disclosure and the foregoing description thereof, without departing from the substance or scope thereof.
- Accordingly, while the present composition and methods have been described herein in detail in relation to its preferred embodiment, it is to be understood that this disclosure is only illustrative and exemplary and is made merely for purposes of providing a full and enabling disclosure.
- The foregoing disclosure is not intended or to be construed to limit or otherwise to exclude any such other embodiments, adaptations, variations, modifications and equivalent arrangements.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/154,934 US20210137107A1 (en) | 2014-11-26 | 2021-01-21 | Surface disinfectant with residual biocidal property |
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462084917P | 2014-11-26 | 2014-11-26 | |
US201562127075P | 2015-03-02 | 2015-03-02 | |
US201562166403P | 2015-05-26 | 2015-05-26 | |
US14/948,962 US11026418B2 (en) | 2014-11-26 | 2015-11-23 | Surface disinfectant with residual biocidal property |
US15/162,068 US11033023B2 (en) | 2014-11-26 | 2016-05-23 | Surface disinfectant with residual biocidal property |
US15/625,612 US10925281B2 (en) | 2014-11-26 | 2017-06-16 | Surface disinfectant with residual biocidal property |
US17/154,934 US20210137107A1 (en) | 2014-11-26 | 2021-01-21 | Surface disinfectant with residual biocidal property |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/625,612 Division US10925281B2 (en) | 2014-11-26 | 2017-06-16 | Surface disinfectant with residual biocidal property |
Publications (1)
Publication Number | Publication Date |
---|---|
US20210137107A1 true US20210137107A1 (en) | 2021-05-13 |
Family
ID=59958389
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/625,612 Active US10925281B2 (en) | 2014-11-26 | 2017-06-16 | Surface disinfectant with residual biocidal property |
US17/154,934 Pending US20210137107A1 (en) | 2014-11-26 | 2021-01-21 | Surface disinfectant with residual biocidal property |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/625,612 Active US10925281B2 (en) | 2014-11-26 | 2017-06-16 | Surface disinfectant with residual biocidal property |
Country Status (1)
Country | Link |
---|---|
US (2) | US10925281B2 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9877875B2 (en) | 2012-10-09 | 2018-01-30 | Parasol Medical LLC | Antimicrobial hydrogel formulation |
US10842147B2 (en) | 2014-11-26 | 2020-11-24 | Microban Products Company | Surface disinfectant with residual biocidal property |
US10925281B2 (en) * | 2014-11-26 | 2021-02-23 | Microban Products Company | Surface disinfectant with residual biocidal property |
US11033023B2 (en) | 2014-11-26 | 2021-06-15 | Microban Products Company | Surface disinfectant with residual biocidal property |
US10834922B2 (en) | 2014-11-26 | 2020-11-17 | Microban Products Company | Surface disinfectant with residual biocidal property |
US11503824B2 (en) | 2016-05-23 | 2022-11-22 | Microban Products Company | Touch screen cleaning and protectant composition |
US20190045791A1 (en) * | 2017-08-10 | 2019-02-14 | Parasol Medical LLC | Solution to prevent the spread of clostridium difficile in a health care facility |
US10967082B2 (en) | 2017-11-08 | 2021-04-06 | Parasol Medical, Llc | Method of limiting the spread of norovirus within a cruise ship |
US20190230929A1 (en) * | 2018-01-30 | 2019-08-01 | W.M. Barr & Company, Inc. | Composition for residual sanitization |
US10822502B2 (en) | 2018-03-06 | 2020-11-03 | Parasol Medical LLC | Antimicrobial solution to apply to a hull and an interior of a boat |
US10864058B2 (en) | 2018-03-28 | 2020-12-15 | Parasol Medical, Llc | Antimicrobial treatment for a surgical headlamp system |
MX2020010625A (en) | 2018-04-09 | 2021-02-26 | Rhodia Operations | Compositions and methods for long lasting disinfection. |
MX2020010626A (en) | 2018-04-09 | 2021-02-26 | Rhodia Operations | Compositions and methods for long lasting disinfection. |
US20200068896A1 (en) * | 2018-09-04 | 2020-03-05 | Parasol Medical LLC | Cleaning composition including both a disinfectant and a long-lasting antimicrobial component |
US11305033B2 (en) | 2019-03-05 | 2022-04-19 | Parasol Medical, Llc | Splinting system including an antimicrobial coating and a method of manufacturing the same |
US20210113437A1 (en) * | 2019-10-18 | 2021-04-22 | Microban Products Company | Wipe substrate having residual disinfectant property |
WO2021173366A1 (en) * | 2020-02-27 | 2021-09-02 | Cao Group, Inc | Short and long-term surface disinfectants utilizing alcohol and zinc pyrithione compositions |
US11753609B1 (en) * | 2021-09-01 | 2023-09-12 | Venus Laboratories, Inc. | Eco-friendly laundry sheet comprising a poly(2-ethyl-2-oxazoline) binder |
WO2023087195A1 (en) * | 2021-11-18 | 2023-05-25 | Ecolab Usa Inc. | Fast drying multi-purpose cleaning and disinfecting compositions and methods of their use |
GB2613865A (en) * | 2021-12-17 | 2023-06-21 | Gama Healthcare Ltd | Universal formulation |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090041705A1 (en) * | 2007-08-07 | 2009-02-12 | Kpss-Kao Professional Salon Services Gmbh | Composition for keratin fibres |
US20090169502A1 (en) * | 2008-01-02 | 2009-07-02 | L'oreal | Compositions and methods for treating keratinous substrates using polyamides |
US10834922B2 (en) * | 2014-11-26 | 2020-11-17 | Microban Products Company | Surface disinfectant with residual biocidal property |
US10842147B2 (en) * | 2014-11-26 | 2020-11-24 | Microban Products Company | Surface disinfectant with residual biocidal property |
US10925281B2 (en) * | 2014-11-26 | 2021-02-23 | Microban Products Company | Surface disinfectant with residual biocidal property |
US11033023B2 (en) * | 2014-11-26 | 2021-06-15 | Microban Products Company | Surface disinfectant with residual biocidal property |
Family Cites Families (175)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2897182A (en) | 1957-09-06 | 1959-07-28 | Rohm & Haas | Oxazine and oxazoline polymers |
US3505297A (en) | 1963-01-21 | 1970-04-07 | Dow Chemical Co | Alkenyl heterocycles and their polymers |
SE302825B (en) | 1965-11-18 | 1968-08-05 | K Rosdahl | |
NL130542C (en) | 1968-08-14 | |||
JPS513336B2 (en) | 1971-09-07 | 1976-02-02 | ||
US3997460A (en) | 1975-04-10 | 1976-12-14 | The Clorox Company | Liquid abrasive cleaner |
US4719105A (en) | 1975-11-05 | 1988-01-12 | Bush Boake Allen, Inc. | Method, compositions and compounds useful in room fresheners employing cyclohexyl alcohol and ester derivatives |
FR2342074A1 (en) | 1976-02-26 | 1977-09-23 | Salkin Nicolas | REMANENT ACTION DISINFECTION PRODUCTS |
US4186191A (en) | 1977-09-06 | 1980-01-29 | The Dow Chemical Company | Novel complexes of polyoxazolines or polyoxazines and halogens, interhalogens or pseudohalogens and process for preparing same |
US4144211A (en) | 1977-09-06 | 1979-03-13 | The Dow Chemical Company | Novel complexes of polyoxazolines or polyoxazines and halogens, interhalogens or pseudo-halogens and process for preparing same |
JPS55120627A (en) | 1979-03-12 | 1980-09-17 | Dow Chemical Co | Novel complex and its manufacture |
US4481167A (en) | 1980-04-11 | 1984-11-06 | The Dow Chemical Company | Sanitizing complexes of polyoxazolines or polyoxazines and polyhalide anions |
US4326977A (en) | 1980-11-10 | 1982-04-27 | Basf Wyandotte Corporation | Liquid antiseptic cleaners with improved foaming properties |
US4408001A (en) | 1981-04-06 | 1983-10-04 | The Dow Chemical Company | Degeneration inhibited sanitizing complexes |
US4486246A (en) | 1983-05-18 | 1984-12-04 | E. F. Houghton & Co. | Polyoxazolines in aqueous quenchants |
US4601954A (en) | 1984-03-30 | 1986-07-22 | Servicemaster Industries, Inc. | Disinfectant formulation |
US4585482A (en) | 1984-05-25 | 1986-04-29 | Southern Research Institute | Long-acting biocidal compositions and method therefor |
US4941989A (en) | 1986-07-16 | 1990-07-17 | Ridgely Products Co., Inc. | Cleansing and disinfecting compositions |
US4837005A (en) | 1986-09-30 | 1989-06-06 | Union Carbide Corporation | Partially hydrolyzed, poly(N-acyl)alkylenimines in personal care |
JPH0776113B2 (en) | 1987-02-16 | 1995-08-16 | 日本硝子繊維株式会社 | Reinforcing material for molding thermoplastic resin or thermosetting resin |
AU605254B2 (en) | 1987-05-12 | 1991-01-10 | Ecolab Inc. | Improved disinfectant polymeric coatings for hard surfaces |
US5061485A (en) | 1987-05-12 | 1991-10-29 | Ecolab Inc. | Disinfectant polymeric coatings for hard surfaces |
AU605217B2 (en) | 1987-05-12 | 1991-01-10 | Ecolab Inc. | Disinfectant polymeric coatings for hard surfaces |
US4999386A (en) | 1987-05-12 | 1991-03-12 | Ecolab Inc. | Disinfectant polymeric coatings from esters of α,β-unsaturated carboxylic acid and germicide |
US4990339A (en) | 1987-11-16 | 1991-02-05 | H. B. Fuller Company | Dermal treatment film |
US4912154A (en) | 1988-12-30 | 1990-03-27 | The Sherwin-Williams Company | Water-dispersible air-drying coatings containing 2-oxazoline groups |
US5032434A (en) | 1989-04-07 | 1991-07-16 | Aluminum Company Of America | Compatibilized blend comprising skin polymer, ethylene-vinyl alcohol copolymer, and poly-2-oxazoline |
US5051124A (en) | 1989-10-24 | 1991-09-24 | Buckman Laboratories International, Inc. | Microbicidal compositions of dimethylamine-epichlorohydrin amines |
US5120531A (en) | 1990-04-06 | 1992-06-09 | The Procter & Gamble Company | Hair styling conditioners |
FR2662174B1 (en) | 1990-05-15 | 1993-10-15 | Eparco | CLEANING AND DISINFECTION COMPOSITIONS FOR HOUSEHOLD USE WITH HYPOALLERGENIC PROPERTIES AND ARACID CAPACITIES. |
JPH0441599A (en) | 1990-06-07 | 1992-02-12 | Kao Corp | Cleaning agent composition |
US5183601A (en) | 1990-06-07 | 1993-02-02 | Kao Corporation | Detergent composition containing polyethylenimine co-polymer |
US5547836A (en) | 1990-08-30 | 1996-08-20 | Tropix, Inc. | Enhancement of chemiluminescent assays |
EP0483426A1 (en) | 1990-11-01 | 1992-05-06 | The Procter & Gamble Company | Thiol heterocyclic deodorant composition and method of deodorization |
JPH0525025A (en) | 1991-07-22 | 1993-02-02 | Kao Corp | Hair-care cosmetics |
ATE150482T1 (en) | 1992-11-16 | 1997-04-15 | Procter & Gamble | TISSUE RINSE COMPOSITIONS CONTAINING DYE TRANSFER INHIBITORS FOR IMPROVED TISSUE APPEARANCE |
JPH08512084A (en) | 1993-07-01 | 1996-12-17 | ザ、プロクター、エンド、ギャンブル、カンパニー | Thermoplastic elastomeric copolymer and hair and skin care compositions containing it |
SG64325A1 (en) | 1993-07-01 | 1999-04-27 | Procter & Gamble | Thermoplastic elasomeric copolymers and hair and skin care compositions containing the same |
US5536505A (en) | 1993-12-15 | 1996-07-16 | Eastman Chemical Company | Controlled release matrix system using cellulose acetate/poly-2-ethyl-2-oxazoline blends |
DE4403952A1 (en) | 1994-02-08 | 1995-08-10 | Henkel Kgaa | Hair treatment agent with polymers |
US5547990A (en) | 1994-05-20 | 1996-08-20 | Lonza, Inc. | Disinfectants and sanitizers with reduced eye irritation potential |
AU693463B2 (en) | 1994-09-19 | 1998-07-02 | Anhay Investments Pty Ltd | Anti-microbial composition |
US5849310A (en) | 1994-10-20 | 1998-12-15 | The Procter & Gamble Company | Personal treatment compositions and/or cosmetic compositions containing enduring perfume |
US5762948A (en) * | 1995-06-07 | 1998-06-09 | Ambi Inc. | Moist bacteriocin disinfectant wipes and methods of using the same |
US5645823A (en) | 1995-07-07 | 1997-07-08 | Thrall; Bernice Eileen | Keratinous tissue conditioner |
US5756145A (en) | 1995-11-08 | 1998-05-26 | Baylor College Of Medicine | Durable, Resilient and effective antimicrobial coating for medical devices and method of coating therefor |
GB9622176D0 (en) | 1996-10-24 | 1996-12-18 | Reckitt & Colman Inc | Improvements in compositions containing organic compounds |
US5776479A (en) | 1996-12-20 | 1998-07-07 | The United States Of America As Represented By The Secretary Of Agriculture | Stable, germicidal film-forming teat-dip solutions |
WO1998029085A2 (en) | 1996-12-31 | 1998-07-09 | American Medical Research, L.L.C. | Skin product having continuing antimicrobial, antiviral, antiseptic, and healing properties |
US6017561A (en) | 1997-04-04 | 2000-01-25 | The Clorox Company | Antimicrobial cleaning composition |
US6165457A (en) | 1997-05-12 | 2000-12-26 | The Procter & Gamble Company | Personal care compositions containing toughened grafted polymers |
US6258368B1 (en) | 1997-06-04 | 2001-07-10 | The Procter & Gamble Company | Antimicrobial wipes |
KR20010013377A (en) | 1997-06-04 | 2001-02-26 | 데이비드 엠 모이어 | Mild, leave-on antimicrobial compositions |
EP1030339B1 (en) | 1997-11-06 | 2004-05-19 | Matsushita Electric Industrial Co., Ltd. | Phosphor material, phosphor material powder, plasma display panel, and processes for producing these |
US6139856A (en) | 1997-12-11 | 2000-10-31 | Biomedical Development Corp. | Composition useful for providing one-step surgical preparation and drape |
EP1047763B1 (en) | 1998-01-12 | 2005-12-07 | The Procter & Gamble Company | Acidic aqueous cleaning compositions |
ES2327369T3 (en) | 1998-02-12 | 2009-10-28 | Surfacine Development Company, Llc | DISINFECTING COMPOUNDS THAT PROVIDE PROLONGED BIOCIDE ACTION. |
US6194075B1 (en) | 1998-06-11 | 2001-02-27 | Arkwright, Incorporated | Water insoluble absorbent coating materials |
US6080387A (en) | 1998-07-15 | 2000-06-27 | The Clorox Company | Aerosol antimicrobial compositions |
US6159924A (en) | 1998-07-24 | 2000-12-12 | Reckitt Benckiser Inc. | Low residue aqueous hard surface cleaning and disinfecting compositions |
GB2340502B (en) | 1998-08-11 | 2002-08-07 | Reckitt & Colman Inc | Alkaline aqueous hard surface treatment compositions |
GB2340501B (en) | 1998-08-11 | 2002-07-03 | Reckitt & Colman Inc | Improvements in or relating to organic compositions |
GB9817457D0 (en) | 1998-08-12 | 1998-10-07 | Reckitt & Colman Inc | Improvements in or related to organic compositions |
JP2002524475A (en) | 1998-09-11 | 2002-08-06 | サーファシン ディベロップメント カンパニー, エルエルシー | Topical transdermal antimicrobial composition |
US20030147925A1 (en) | 1998-09-11 | 2003-08-07 | Samuel P. Sawan | Topical dermal antimicrobial compositions, methods for generating same, and monitoring methods utilizing same |
WO2000054587A1 (en) | 1999-03-16 | 2000-09-21 | Coating Systems Laboratories, Inc. | Antimicrobial skin preparations containing organosilane quaternaries |
US6110387A (en) | 1999-04-22 | 2000-08-29 | Albemarle Corporation | Sulfamate stabilization of a bromine biocide in water |
GB9911818D0 (en) | 1999-05-21 | 1999-07-21 | Reckitt & Colman Inc | Improvements in or relating to organic compositions |
GB9911816D0 (en) | 1999-05-21 | 1999-07-21 | Reckitt & Colman Inc | Improvements in or relating to organic compositions |
US6716805B1 (en) | 1999-09-27 | 2004-04-06 | The Procter & Gamble Company | Hard surface cleaning compositions, premoistened wipes, methods of use, and articles comprising said compositions or wipes and instructions for use resulting in easier cleaning and maintenance, improved surface appearance and/or hygiene under stress conditions such as no-rinse |
US6616922B2 (en) | 2001-03-27 | 2003-09-09 | The Dial Corporation | Antibacterial compositions |
US20030114342A1 (en) | 2001-09-20 | 2003-06-19 | Lonza Inc. | Compositions comprising quaternary ammonium compounds and dendritic polymers with antimicrobial activity |
US6797278B2 (en) | 2001-12-21 | 2004-09-28 | Milliken & Company | Antimicrobial sol-gel films comprising specific metal-containing antimicrobial agents |
US20050042240A1 (en) | 2002-01-28 | 2005-02-24 | Utterberg David S. | High viscosity antibacterials |
US20030143264A1 (en) | 2002-01-30 | 2003-07-31 | Vincent Margiotta | Topical anesthetic-antiseptic patch |
US20030158076A1 (en) | 2002-02-08 | 2003-08-21 | Rodrigues Klein A. | Amide polymers for use in surface protecting formulations |
US7299805B2 (en) | 2002-06-07 | 2007-11-27 | Marctec, Llc | Scaffold and method for implanting cells |
US20050008676A1 (en) | 2002-12-19 | 2005-01-13 | Yongxing Qiu | Medical devices having antimicrobial coatings thereon |
US7488757B2 (en) | 2003-03-24 | 2009-02-10 | Becton, Dickinson And Company | Invisible antimicrobial glove and hand antiseptic |
US7491753B2 (en) | 2003-07-03 | 2009-02-17 | Mallard Creek Polymers, Inc. | Antimicrobial and antistatic polymers and methods of using such polymers on various substrates |
WO2005035382A1 (en) | 2003-10-07 | 2005-04-21 | Henkel Kommanditgesellschaft Auf Aktien | Film packed agent portion and method for producing |
GB2407581A (en) | 2003-11-01 | 2005-05-04 | Reckitt Benckiser Inc | Hard surface cleaning and disinfecting compositions |
ITFI20030279A1 (en) | 2003-11-03 | 2005-05-04 | Sicem Ind S P A | USE OF SULFUR FOR THE ELIMINATION OF THE BAD SMELL EMITTED BY FEET, BY APPLICATION BOTH TO TEXTILE PRODUCTS SUCH AS YARNS, VARIOUS COMPOSITION FABRICS, SOCKS, SOCKS AND THE LIKE, WHICH TO PRODUCTS SHOE MAKERS, |
JP2005154965A (en) | 2003-11-27 | 2005-06-16 | Toyobo Co Ltd | Bioresistant fiber cloth, method for producing the same and textile product made thereof |
US8268337B2 (en) | 2004-05-14 | 2012-09-18 | Wheeler Jack A | Nontoxic killer of E. coli and other problem microorganisms |
US20060068024A1 (en) | 2004-09-27 | 2006-03-30 | Schroeder Kurt M | Antimicrobial silver halide composition |
WO2006086271A2 (en) | 2005-02-07 | 2006-08-17 | Jacques Elfersy | Methods and compositions for biocidal treatments |
CA2602100A1 (en) | 2005-03-16 | 2006-09-28 | Musculoskeletal Transplant Foundation | Soft tissue processing |
US20060269441A1 (en) | 2005-05-25 | 2006-11-30 | Ochomogo Maria G | Nanosilica-based food contact sanitizer |
US20070023129A1 (en) | 2005-07-29 | 2007-02-01 | Stieler David C | Method of coupling polymeric tubing to polymeric coated metal tubing |
US8153613B2 (en) | 2006-05-24 | 2012-04-10 | Delaval Holding Ab | Barrier film-forming germicidal composition for controlling mastitis |
US8343523B2 (en) | 2005-08-22 | 2013-01-01 | Quick-Med Technologies, Inc. | Disinfectant with durable activity based on alcohol-soluble quaternary ammonium polymers and copolymers |
US8343473B2 (en) | 2005-08-24 | 2013-01-01 | Purdue Research Foundation | Hydrophilized antimicrobial polymers |
WO2007070801A2 (en) | 2005-12-12 | 2007-06-21 | Allaccem, Inc. | Methods and systems for preparing antimicrobial films and coatings |
US20070166403A1 (en) | 2006-01-11 | 2007-07-19 | Amino Solutions, Llc | Method and Compound for Treating Mold |
AU2007209376B2 (en) | 2006-01-27 | 2013-02-07 | Basf Se | Polymeric anti-microbial agents |
US9295619B2 (en) | 2006-02-08 | 2016-03-29 | Cao Group, Inc. | Dental treatment compositions and conformable dental treatment trays using the same |
US9668476B2 (en) | 2006-02-23 | 2017-06-06 | Lanxess Corporation | Removable antimicrobial coating compositions and methods of use |
WO2007101445A1 (en) | 2006-03-08 | 2007-09-13 | Glad, Thomas Christian | Biocidal cleaning compositions |
JP2007270374A (en) | 2006-03-31 | 2007-10-18 | Komatsu Seiren Co Ltd | Water repellent and oil repellent cloth and method for producing the same |
GB2437282A (en) | 2006-04-19 | 2007-10-24 | 3M Innovative Properties Co | Polyethyloxazoline adhesives |
ATE449590T1 (en) | 2006-04-28 | 2009-12-15 | Ivoclar Vivadent Ag | DENTAL MATERIALS BASED ON RADICALLY POLYMERIZABLE MACROMERS WITH ANTIMICROBIAL EFFECT |
US7541321B2 (en) | 2006-07-26 | 2009-06-02 | Innovation Services, Inc. | Water soluble barrier film conformal coating composition |
AR063704A1 (en) | 2006-09-14 | 2009-02-11 | Makhteshim Chem Works Ltd | PESTICIDE NANOPARTICLES OBTAINED OBTAINED FROM MICROEMULSIONS AND NANOEMULSIONS |
AU2007308351B2 (en) | 2006-10-25 | 2013-05-16 | Innovative Water Care, Llc | Controlled Foam Alkyl Quat Formulations |
JP2010509467A (en) | 2006-11-08 | 2010-03-25 | マサチューセッツ インスティテュート オブ テクノロジー | Polymer coating to inactivate viruses and bacteria |
EP2094790A2 (en) | 2006-11-27 | 2009-09-02 | Microactive Corp. | Controlled gas release from a melt processable compatible polymer blend |
DE102006058956A1 (en) | 2006-12-12 | 2008-06-19 | Sanitized Ag | Antimicrobial composition for finishing textiles |
KR101395366B1 (en) | 2007-02-05 | 2014-05-14 | 다우 글로벌 테크놀로지스 엘엘씨 | Modified polyamide membrane |
WO2008100993A1 (en) | 2007-02-13 | 2008-08-21 | Bristol-Myers Squibb Company | Deodorant compositions for body waste collectors |
US7820068B2 (en) | 2007-02-21 | 2010-10-26 | Houghton Technical Corp. | Chemical assisted lapping and polishing of metals |
RU2329286C1 (en) | 2007-03-07 | 2008-07-20 | Общество с ограниченной ответственностью "Эвима-М" | Method of prolonged disinfection of premises, equipment, preservation and disinfection of water |
DE102007019044A1 (en) | 2007-04-20 | 2008-10-23 | Henkel Ag & Co. Kgaa | Kit for applying a polymerizable adhesive composition to tissue |
JP2010529262A (en) | 2007-06-07 | 2010-08-26 | ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク | Long lasting disinfectant cleaner |
US8440606B2 (en) | 2007-07-12 | 2013-05-14 | Kimberly-Clark Worldwide, Inc. | Foaming hand sponge for bodily cleansing with color change indicator |
US8343908B2 (en) | 2007-07-12 | 2013-01-01 | Kimberly-Clark Worldwide, Inc. | Foaming hand sponge with color change indicator |
GB0713799D0 (en) | 2007-07-17 | 2007-08-22 | Byotrol Llc | Anti-microbial compositions |
EP2070508B1 (en) * | 2007-12-14 | 2018-08-22 | Johnson & Johnson GmbH | Skin-care composition |
WO2009089346A2 (en) | 2008-01-08 | 2009-07-16 | Quick-Med Technologies, Inc. | Disinfectant alcohol-soluble quaternary ammonium polymers |
CN101971057B (en) | 2008-03-18 | 2013-03-27 | 诺瓦提斯公司 | Coating process for ophthalmic lenses |
CN102083308A (en) | 2008-04-11 | 2011-06-01 | 贝尔法斯特女王大学 | Antimicrobial system |
US9402908B2 (en) | 2008-06-26 | 2016-08-02 | Alexander V. Kabanov | Polymeric delivery systems for active agents |
CN102215874B (en) | 2008-06-26 | 2016-07-06 | 慕尼黑工业大学 | The polymeric delivery systems of activating agent |
US20100062966A1 (en) | 2008-09-09 | 2010-03-11 | Novipella, Inc. | Self-cleaning thin-film forming compositions |
CN101473825A (en) | 2008-12-18 | 2009-07-08 | 孙家隆 | Bactericide agent composition containing mepanipyrim and oxpoconazole |
US7704935B1 (en) | 2009-01-06 | 2010-04-27 | Becton, Dickinson And Company | Chlorhexidine acetate antiseptic cleaning agent |
US20100189595A1 (en) | 2009-01-29 | 2010-07-29 | Lehigh Tecghnologies Inc. | Method of Controlling Organoleptic Odors |
WO2010086850A2 (en) | 2009-01-29 | 2010-08-05 | Digiflex Ltd. | Process for producing a photomask on a photopolymeric surface |
FR2941971B1 (en) | 2009-02-09 | 2011-04-01 | Creat | METHOD FOR FUNCTIONALIZING A TEXTILE SUBSTRATE TO CONFER HEPO-PHOBIC AND OLEOPHOBIC PROPERTIES |
CN104069546B (en) | 2009-02-25 | 2020-07-03 | 奥索邦德公司 | Anti-infective functionalized surfaces and methods of making same |
US8317934B2 (en) | 2009-05-13 | 2012-11-27 | Lam Research Corporation | Multi-stage substrate cleaning method and apparatus |
US20100305064A1 (en) * | 2009-05-29 | 2010-12-02 | Walsh Star M | Topical skin care compositions |
CN102459747B (en) | 2009-06-08 | 2015-09-30 | 奎克-麦德技术公司 | Comprise the antibacterial textile of peroxide |
CN102481264B (en) | 2009-06-29 | 2015-04-22 | 本德尔分析控股有限公司 | Drug delivery system comprising polyoxazoline and a bioactive agent |
US20110177146A1 (en) | 2009-07-27 | 2011-07-21 | E. I. Du Pont De Nemours And Company | Removable antimicrobial coating compositions containing cationic rheology agent and methods of use |
RU2536925C2 (en) | 2009-09-28 | 2014-12-27 | ДАУ ГЛОБАЛ ТЕКНОЛОДЖИЗ ЭлЭлСи | Dibromomalonamide composition and thereof application as biocide |
GB0920722D0 (en) | 2009-11-26 | 2010-01-13 | Byotrol Plc | Anti-microbial wipes |
CN101715784A (en) | 2009-12-16 | 2010-06-02 | 武汉天仪巨微科技有限公司 | Broad-spectrum long-acting anti-pathogen antiviral disinfectant, preparation method and application thereof |
WO2011103158A1 (en) | 2010-02-16 | 2011-08-25 | Michael Darryl Black | Systems and methods that kill infectious agents (bacteria) without the use of a systemic anti-biotic |
MX2012011400A (en) | 2010-04-12 | 2014-04-14 | Georgia Pacific Consumer Prod | Cleaning wipe for use with disinfectants, method of manufacture thereof, and system. |
GB201008912D0 (en) | 2010-05-27 | 2010-07-14 | Gx Labs Holdings Ltd | Biocidal coating composition |
US20120034287A1 (en) | 2010-08-03 | 2012-02-09 | Napolitano Lisa A | Quaternary Ammonium Glycol Ether Disinfectant Wipes |
US20120148751A1 (en) | 2010-12-14 | 2012-06-14 | Ecolab Usa Inc. | Wear resistant antimicrobial compositions and methods of use |
KR20120077821A (en) | 2010-12-31 | 2012-07-10 | 주식회사 삼양바이오팜 | Matrix type antimicrobial vehicle and manufacturing method thereof |
JP6092121B2 (en) | 2011-01-09 | 2017-03-08 | エイエヌピー テクノロジーズ, インコーポレイテッド | Branched polymer aggregates induced by hydrophobic molecules and uses thereof |
WO2012097245A1 (en) | 2011-01-14 | 2012-07-19 | Board Of Regents Of The University Of Nebraska | Water soluble fullerene formulations and methods of use thereof |
US9089140B2 (en) | 2011-02-23 | 2015-07-28 | Sanikleen, Llc | Cleaning and sanitizing film |
GB201107183D0 (en) | 2011-04-28 | 2011-06-15 | Gx Labs Holdings Ltd | Biocide-coated substrate |
AT511386B1 (en) | 2011-05-03 | 2013-03-15 | Ke Kelit Kunststoffwerk Gmbh | KONTAKTBIOZID |
CN102965214A (en) | 2011-08-31 | 2013-03-13 | 东友Fine-Chem股份有限公司 | Cleaning composition |
US9517193B2 (en) | 2011-10-04 | 2016-12-13 | Isp Investment Llc | Antiperspirant/deodorant compositions |
KR102066298B1 (en) | 2011-11-28 | 2020-01-14 | 히프로테크, 인크. | Catheter devices and techniques |
US9445600B2 (en) | 2011-12-29 | 2016-09-20 | Medivators Inc. | Low pH disinfectant composition |
US20140011766A1 (en) | 2012-01-24 | 2014-01-09 | Randall W. Krafft | Antimicrobial compositions and methods |
US9039967B2 (en) | 2012-02-06 | 2015-05-26 | Hyprotek, Inc. | Antiseptic applicators and packaging techniques |
EP2817353B1 (en) | 2012-02-20 | 2021-01-13 | Basf Se | Enhancing the antimicrobial activity of biocides with polymers |
WO2013173733A1 (en) | 2012-05-18 | 2013-11-21 | 3D Systems, Inc. | Support structures and deposition techniques for 3d printing |
FR2994095A1 (en) | 2012-08-02 | 2014-02-07 | Univ Lorraine | New polymer having pyrrolidinium units, useful as an antibacterial agent, biocide agent, bacteriostatic agent, and disinfectant agent |
JP6058961B2 (en) | 2012-09-28 | 2017-01-11 | ユニチカトレーディング株式会社 | Polyester fiber fabric, method for producing the same, and clothing using the same |
US20140121230A1 (en) | 2012-11-01 | 2014-05-01 | Emmanuel Gonzales De Asis | Topical parasiticidal formulation |
US9718920B2 (en) | 2012-12-19 | 2017-08-01 | 3M Innovative Properties Company | Reactive polyoxazolines having a perfluorinated group |
JP6305429B2 (en) | 2012-12-19 | 2018-04-04 | スリーエム イノベイティブ プロパティズ カンパニー | Polyoxazoline copolymer |
PT2945653T (en) | 2012-12-20 | 2017-10-30 | Quick-Med Tech Inc | Regeneration of antimicrobial coatings containing metal derivatives upon exposure to aqueous hydrogen peroxide |
US20140220331A1 (en) | 2013-02-02 | 2014-08-07 | Cosilion LLC | Antimicrobial compositions |
CA2906617C (en) | 2013-03-15 | 2021-11-02 | Richard WOLBERS | Protective water reversible clear coating for substrates |
CN103161071B (en) | 2013-04-15 | 2015-08-19 | 天津市中科健新材料技术有限公司 | A kind of bacteriostatic non-woven cloth and preparation method thereof |
US9237831B1 (en) * | 2013-08-22 | 2016-01-19 | Georgia-Pacific Consumer Products Lp | Water soluble sheet soap in a waterless pump bottle, ready to make a foam cleanser by adding water |
JP2015089975A (en) | 2013-11-06 | 2015-05-11 | ツヤック株式会社 | Deodorant and processing method of the deodorant to fabric or yarn |
PL3079467T3 (en) | 2013-11-27 | 2020-01-31 | Ecolab Usa Inc. | Disinfectant cleaner composition having tuberculocidal efficacy and efficacy against specific viruses |
US20150190543A1 (en) | 2014-01-06 | 2015-07-09 | Verdex Technologies Inc. | Coform nanofibrous superabsorbent materials |
CA3233656A1 (en) | 2014-08-28 | 2016-03-03 | Zhengbing Cao | Antimicrobial compositions and methods with novel polymeric binding system |
WO2017091251A1 (en) | 2015-11-23 | 2017-06-01 | Microban Products Company | Surface disinfectant with residual biocidal property |
CA3005597A1 (en) | 2015-11-23 | 2017-06-01 | Microban Products Company | Surface disinfectant with residual biocidal property |
US11503824B2 (en) | 2016-05-23 | 2022-11-22 | Microban Products Company | Touch screen cleaning and protectant composition |
US20170335510A1 (en) | 2016-05-23 | 2017-11-23 | Microban Products Company | Odor adsorbent composition and method for use in polymers |
-
2017
- 2017-06-16 US US15/625,612 patent/US10925281B2/en active Active
-
2021
- 2021-01-21 US US17/154,934 patent/US20210137107A1/en active Pending
Patent Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090041705A1 (en) * | 2007-08-07 | 2009-02-12 | Kpss-Kao Professional Salon Services Gmbh | Composition for keratin fibres |
US20090169502A1 (en) * | 2008-01-02 | 2009-07-02 | L'oreal | Compositions and methods for treating keratinous substrates using polyamides |
US10834922B2 (en) * | 2014-11-26 | 2020-11-17 | Microban Products Company | Surface disinfectant with residual biocidal property |
US10842147B2 (en) * | 2014-11-26 | 2020-11-24 | Microban Products Company | Surface disinfectant with residual biocidal property |
US10925281B2 (en) * | 2014-11-26 | 2021-02-23 | Microban Products Company | Surface disinfectant with residual biocidal property |
US20210076674A1 (en) * | 2014-11-26 | 2021-03-18 | Microban Products Company | Surface disinfectant with residual biocidal property |
US20210076671A1 (en) * | 2014-11-26 | 2021-03-18 | Microban Products Company | Surface disinfectant with residual biocidal property |
US11026418B2 (en) * | 2014-11-26 | 2021-06-08 | Microban Products Company | Surface disinfectant with residual biocidal property |
US11033023B2 (en) * | 2014-11-26 | 2021-06-15 | Microban Products Company | Surface disinfectant with residual biocidal property |
US20210267195A1 (en) * | 2014-11-26 | 2021-09-02 | Microban Products Company | Surface disinfectant with residual biocidal property |
US20210282392A1 (en) * | 2014-11-26 | 2021-09-16 | Microban Products Company | Surface disinfectant with residual biocidal property |
US20210282396A1 (en) * | 2014-11-26 | 2021-09-16 | Microban Products Company | Surface disinfectant with residual biocidal property |
US11134678B2 (en) * | 2014-11-26 | 2021-10-05 | Microban Products Company | Surface disinfectant with residual biocidal property |
US11134674B2 (en) * | 2014-11-26 | 2021-10-05 | Microban Products Company | Surface disinfectant with residual biocidal property |
US20210392883A1 (en) * | 2014-11-26 | 2021-12-23 | Microban Products Company | Surface disinfectant with residual biocidal property |
US20210392878A1 (en) * | 2014-11-26 | 2021-12-23 | Microban Products Company | Surface disinfectant with residual biocidal property |
Also Published As
Publication number | Publication date |
---|---|
US10925281B2 (en) | 2021-02-23 |
US20170280716A1 (en) | 2017-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11134674B2 (en) | Surface disinfectant with residual biocidal property | |
US11134678B2 (en) | Surface disinfectant with residual biocidal property | |
US10925281B2 (en) | Surface disinfectant with residual biocidal property | |
US11033023B2 (en) | Surface disinfectant with residual biocidal property | |
CA3005597A1 (en) | Surface disinfectant with residual biocidal property | |
CA3005601A1 (en) | Surface disinfectant with residual biocidal property | |
CA3063749A1 (en) | Surface disinfectant with residual biocidal property | |
RU2777991C2 (en) | Surface action disinfectant with residual biocidal property | |
RU2778401C2 (en) | Surface-acting disinfectant with residual biocide property |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
AS | Assignment |
Owner name: W.M. BARR & COMPANY, INC., TENNESSEE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SHIREMAN, DENNIS EARL;KAVCHOK, KEVIN ANDREW;HAWES, CHARLES L.;AND OTHERS;SIGNING DATES FROM 20160317 TO 20170616;REEL/FRAME:059376/0693 Owner name: MICROBAN PRODUCTS COMPANY, NORTH CAROLINA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LAN, TIAN;AYLWARD, BRIAN PATRICK;HANNA, SAMUEL JAMES;AND OTHERS;SIGNING DATES FROM 20160419 TO 20170619;REEL/FRAME:059376/0682 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
AS | Assignment |
Owner name: MICROBAN PRODUCTS COMPANY, NORTH CAROLINA Free format text: NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:W.M. BARR & COMPANY;REEL/FRAME:062498/0718 Effective date: 20221130 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |